7-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-quinol in-2-one
| Title | Journal |
|---|---|
| Why are most phospholipidosis inducers also hERG blockers? | Archives of toxicology 20171201 |
| Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients with Schizophrenia. | American health & drug benefits 20160301 |
| Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents. | Clinical schizophrenia & related psychoses 20160101 |
| Biological conversion of aripiprazole lauroxil - An N-acyloxymethyl aripiprazole prodrug. | Results in pharma sciences 20140101 |
| Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors. | European journal of medicinal chemistry 20130201 |
| Modeling alcohol self-administration in the human laboratory. | Current topics in behavioral neurosciences 20130101 |
| Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. | Neuropharmacology 20130101 |
| Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder. | Progress in neuro-psychopharmacology & biological psychiatry 20121203 |
| Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization. | International journal of pharmaceutics 20121115 |
| Determination of aripiprazole in rat plasma and brain using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry. | Biomedical chromatography : BMC 20121101 |
| Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells. | Journal of neural transmission (Vienna, Austria : 1996) 20121101 |
| Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up. | Journal of the American Academy of Child and Adolescent Psychiatry 20121101 |
| A prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophrenia. | European psychiatry : the journal of the Association of European Psychiatrists 20121001 |
| New treatment guidelines for acute bipolar mania: a critical review. | Journal of affective disorders 20121001 |
| Association analysis of ZNF804A (zinc finger protein 804A) rs1344706 with therapeutic response to atypical antipsychotics in first-episode Chinese patients with schizophrenia. | Comprehensive psychiatry 20121001 |
| Preliminary studies of (99m)Tc-memantine derivatives for NMDA receptor imaging. | Nuclear medicine and biology 20121001 |
| Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder. | Psychopharmacology 20121001 |
| Is there a role for loading dose regimes in aripiprazole therapy? | The Australian and New Zealand journal of psychiatry 20121001 |
| A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania. | International journal of psychiatry in clinical practice 20121001 |
| Impact of switching or initiating antipsychotic treatment on body weight during a 6-month follow-up in a cohort of patients with schizophrenia. | Journal of clinical psychopharmacology 20121001 |
| Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial). | Depression and anxiety 20121001 |
| Lack of a pharmacokinetic drug-drug interaction between lithium and valproate when co-administered with aripiprazole. | Journal of clinical pharmacy and therapeutics 20121001 |
| Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance. | Expert opinion on pharmacotherapy 20121001 |
| New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress? | Clinical schizophrenia & related psychoses 20121001 |
| Neurite outgrowth mediated by the heat shock protein Hsp90α: a novel target for the antipsychotic drug aripiprazole. | Translational psychiatry 20121001 |
| Aggression and self-injury in a patient with severe autism. | Pediatric annals 20121001 |
| Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia. | Psychiatry and clinical neurosciences 20121001 |
| Aripiprazole, alcohol and substance abuse: a review. | European review for medical and pharmacological sciences 20121001 |
| Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis. | Schizophrenia bulletin 20120901 |
| Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient. | Journal of clinical pharmacology 20120901 |
| Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol. | Journal of psychopharmacology (Oxford, England) 20120901 |
| Neurocognitive effects of aripiprazole in adolescents and young adults with bipolar disorder. | Nordic journal of psychiatry 20120901 |
| Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study. | Journal of psychopharmacology (Oxford, England) 20120901 |
| Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier. | Biopharmaceutics & drug disposition 20120901 |
| Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. | Expert opinion on drug safety 20120901 |
| Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia. | Human psychopharmacology 20120901 |
| [Dysphagia or dysphagias during neuroleptic medication?]. | L'Encephale 20120901 |
| Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists. | Journal of medicinal chemistry 20120823 |
| A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia. | Expert opinion on pharmacotherapy 20120801 |
| Hyperprolactinaemia on depot risperidone treated with aripiprazole. | The Australian and New Zealand journal of psychiatry 20120801 |
| Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials. | Current psychiatry reports 20120801 |
| Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients. | Journal of clinical psychopharmacology 20120801 |
| The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders. | Journal of child and adolescent psychopharmacology 20120801 |
| A comparison of the effects of the dopamine partial agonists aripiprazole and (-)-3-PPP with quinpirole on stimulated dopamine release in the rat striatum: Studies using fast cyclic voltammetry in vitro. | European journal of pharmacology 20120705 |
| Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia. | Schizophrenia bulletin 20120701 |
| Increased Cdk5/p35 activity in the dentate gyrus mediates depressive-like behaviour in rats. | The international journal of neuropsychopharmacology 20120701 |
| Olanzapine and benztropine as a cause of ischemic colitis in a 27-year-old man. | Journal of clinical gastroenterology 20120701 |
| Treatment practices in Tourette syndrome: the European perspective. | European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20120701 |
| Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457. | Psychopharmacology 20120701 |
| Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study. | International clinical psychopharmacology 20120701 |
| Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats. | Pharmaceutical research 20120701 |
| Efficacy and safety of aripiprazole in child and adolescent patients. | European child & adolescent psychiatry 20120701 |
| An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants. | International clinical psychopharmacology 20120701 |
| Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia. | Acta psychiatrica Scandinavica 20120701 |
| Safety and tolerability of antipsychotic polypharmacy. | Expert opinion on drug safety 20120701 |
| Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months. | Human psychopharmacology 20120701 |
| [Therapy of tic disorders]. | Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20120701 |
| Systemic review of aripiprazole for the treatment of children and adolescents with tic disorders. | Neurosciences (Riyadh, Saudi Arabia) 20120701 |
| INN common stem: -piprazole. | Prescrire international 20120701 |
| [Fewer side effects and lower mortality from modern antipsychotic drugs. But they are more expensive than older antipsychotics, based on a study from Västra Götaland]. | Lakartidningen 20120701 |
| Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians. | Postgraduate medicine 20120701 |
| [Pharmacotherapy for conduct disorder in children and adolescents]. | Harefuah 20120701 |
| Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks. | Journal of medicinal chemistry 20120614 |
| Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients. | Journal of psychopharmacology (Oxford, England) 20120601 |
| Slow dissociation of partial agonists from the D₂ receptor is linked to reduced prolactin release. | The international journal of neuropsychopharmacology 20120601 |
| Tolerability profile of aripiprazole in patients with Tourette syndrome. | Journal of psychopharmacology (Oxford, England) 20120601 |
| Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature. | Journal of clinical pharmacy and therapeutics 20120601 |
| Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone. | International journal of psychiatry in clinical practice 20120601 |
| Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms. | International journal of psychiatry in clinical practice 20120601 |
| Is rational antipsychotic polytherapy feasible? A selective review. | Current psychiatry reports 20120601 |
| The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients. | Journal of psychiatric research 20120601 |
| Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique. | AAPS PharmSciTech 20120601 |
| A retrospective review of the effectiveness of aripiprazole in the treatment of sensory abnormalities in autism. | Journal of child and adolescent psychopharmacology 20120601 |
| Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis. | Journal of clinical psychopharmacology 20120601 |
| Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice. | Behavioural pharmacology 20120601 |
| Oral aripiprazole-induced severe hypoglycemia. | Therapeutic drug monitoring 20120601 |
| Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. | European archives of psychiatry and clinical neuroscience 20120601 |
| Chemical structure does not define obviousness. | Nature reviews. Drug discovery 20120601 |
| Aripiprazole salts. II. Aripiprazole perchlorate. | Acta crystallographica. Section C, Crystal structure communications 20120601 |
| Rash in psychiatric and nonpsychiatric adolescent patients receiving lamotrigine in Korea: a retrospective cohort study. | Psychiatry investigation 20120601 |
| Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. | Journal of managed care pharmacy : JMCP 20120601 |
| Aripiprazole for autism spectrum disorders (ASD). | The Cochrane database of systematic reviews 20120516 |
| Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response. | Physiology & behavior 20120515 |
| Risk factors for ileus in patients with schizophrenia. | Schizophrenia bulletin 20120501 |
| Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis. | Journal of psychopharmacology (Oxford, England) 20120501 |
| Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120501 |
| Factors influencing the adherence of antipsychotic medication (Aripiprazole) in first-episode psychosis: findings from a grounded theory study. | Journal of psychiatric and mental health nursing 20120501 |
| Aripiprazole vs placebo for schizophrenia. | Schizophrenia bulletin 20120501 |
| Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy. | International clinical psychopharmacology 20120501 |
| New directions in the treatment of autism spectrum disorders from animal model research. | Expert opinion on drug discovery 20120501 |
| Maintenance therapies in bipolar disorders. | Bipolar disorders 20120501 |
| Review of the pharmacotherapy of irritability of autism. | Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20120501 |
| Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder. | The Annals of pharmacotherapy 20120501 |
| Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study. | The Journal of clinical psychiatry 20120501 |
| Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120501 |
| Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone. | Progress in neuro-psychopharmacology & biological psychiatry 20120427 |
| The complexity of hydration of phloroglucinol: a comprehensive structural and thermodynamic characterization. | The journal of physical chemistry. B 20120405 |
| Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20120401 |
| The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state. | The Journal of clinical psychiatry 20120401 |
| The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium. | Journal of clinical psychopharmacology 20120401 |
| Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study. | Journal of child and adolescent psychopharmacology 20120401 |
| Effects of paroxetine on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia. | Therapeutic drug monitoring 20120401 |
| Tardive laryngeal dystonia associated with aripiprazole monotherapy. | Journal of clinical psychopharmacology 20120401 |
| Determination of a highly selective mixed-affinity sigma receptor ligand, in rat plasma by ultra performance liquid chromatography mass spectrometry and its application to a pharmacokinetic study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120401 |
| Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole. | Psychiatry and clinical neurosciences 20120401 |
| Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials. | Clinical therapeutics 20120401 |
| Aripiprazole salts. I. Aripiprazole nitrate. | Acta crystallographica. Section C, Crystal structure communications 20120401 |
| Efficacy of aripiprazole in comorbid addiction in bipolar disorder. | CNS neuroscience & therapeutics 20120401 |
| [Methodological approach to inter 'guideline' variability in the management of bipolar disorders]. | L'Encephale 20120401 |
| Hiccup: mystery, nature and treatment. | Journal of neurogastroenterology and motility 20120401 |
| An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite. | Journal of pharmaceutical and biomedical analysis 20120325 |
| High dosage of aripiprazole-induced dysphagia. | The International journal of eating disorders 20120301 |
| Methamphetamine-associated psychosis. | Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20120301 |
| Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE). | European archives of psychiatry and clinical neuroscience 20120301 |
| Aripiprazole induced transient myopia: a case report and review of literature. | Cutaneous and ocular toxicology 20120301 |
| Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. | The international journal of neuropsychopharmacology 20120301 |
| Clozapine resistance: augmentation strategies. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120301 |
| Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats. | Psychopharmacology 20120301 |
| Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. | The Journal of clinical psychiatry 20120301 |
| Effect of vehicle systems, pH and enhancers on the permeation of highly lipophilic aripiprazole from Carbopol 971P gel systems across human cadaver skin. | Drug development and industrial pharmacy 20120301 |
| State of the art: treatment of bipolar disorders. | CNS neuroscience & therapeutics 20120301 |
| Refractoriness in bipolar disorder: definitions and evidence-based treatment. | CNS neuroscience & therapeutics 20120301 |
| Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice. | Drug metabolism and disposition: the biological fate of chemicals 20120301 |
| Atypical antipsychotic-induced mania/hypomania: a review of recent case reports and clinical studies. | International journal of psychiatry in clinical practice 20120301 |
| [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy]. | Psychiatrische Praxis 20120301 |
| No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial. | International clinical psychopharmacology 20120301 |
| Neurobiology of schizophrenia: from outcome to pathophysiological insights. | European archives of psychiatry and clinical neuroscience 20120301 |
| Loxapine P-glycoprotein interactions in vitro. | Drug metabolism letters 20120301 |
| Aripiprazole may be free from tachyphylaxis: preliminary findings. | Psychiatry and clinical neurosciences 20120301 |
| Interactions between antiepileptics and second-generation antipsychotics. | Expert opinion on drug metabolism & toxicology 20120301 |
| Emerging drugs for major depressive disorder. | Expert opinion on emerging drugs 20120301 |
| Emergence of psychotic symptoms during Internet withdrawal. | Psychiatry and clinical neurosciences 20120301 |
| Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20120301 |
| Does aripiprazole protect from serotonin syndrome? | Psychiatria Danubina 20120301 |
| Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database. | PLoS medicine 20120301 |
| [Medication review for dementia patients]. | Medizinische Monatsschrift fur Pharmazeuten 20120301 |
| Drug-induced parkinsonism. | Journal of clinical neurology (Seoul, Korea) 20120301 |
| Trends in combination antipsychotic use among persons with commercial insurance: a data snapshot. | Innovations in clinical neuroscience 20120301 |
| Modeling of bias for the analysis of receptor signaling in biochemical systems. | Biochemistry 20120214 |
| Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. | Psychopharmacology 20120201 |
| Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120201 |
| Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission. | Neuropharmacology 20120201 |
| Comparison of academic and nonacademic sites in multi-center clinical trials. | Journal of clinical psychopharmacology 20120201 |
| The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial. | Journal of clinical psychopharmacology 20120201 |
| Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia. | Journal of clinical psychopharmacology 20120201 |
| A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder. | Journal of affective disorders 20120201 |
| Intermittent aripiprazole for schizophrenia. | Schizophrenia research 20120201 |
| Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. | Journal of the American Academy of Child and Adolescent Psychiatry 20120201 |
| The role of antipsychotics in the management of fibromyalgia. | CNS drugs 20120201 |
| Aripiprazole: a review of its use in the management of schizophrenia in adults. | CNS drugs 20120201 |
| Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). | Bipolar disorders 20120201 |
| Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis. | Gender medicine 20120201 |
| The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup. | The western journal of emergency medicine 20120201 |
| [Pharmacology of antipsychotics at human dopamine D2 and D3 receptors]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20120201 |
| Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazole. | Progress in neuro-psychopharmacology & biological psychiatry 20120110 |
| Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. | Schizophrenia bulletin 20120101 |
| Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder. | CNS neuroscience & therapeutics 20120101 |
| The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine. | European journal of clinical pharmacology 20120101 |
| Granulomatous cutaneous lesions associated with risperidone-induced hyperprolactinemia in an amputated upper limb. | International journal of dermatology 20120101 |
| The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis. | General hospital psychiatry 20120101 |
| Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia. | Journal of medical economics 20120101 |
| Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study. | Pharmacopsychiatry 20120101 |
| Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia. | Parkinson's disease 20120101 |
| Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders - 5. | Current opinion in psychiatry 20120101 |
| Hereditary spastic paraplegia and psychosis: connected by the corpus callosum? | Psychosomatics 20120101 |
| Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder. | The Journal of clinical psychiatry 20120101 |
| Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder. | Drugs 20120101 |
| Do we really know how to treat a child with bipolar disorder or one with severe mood dysregulation? Is there a magic bullet? | Depression research and treatment 20120101 |
| Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients. | Human psychopharmacology 20120101 |
| Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population. | Annals of general psychiatry 20120101 |
| Effects of paliperidone extended release on the symptoms and functioning of schizophrenia. | BMC clinical pharmacology 20120101 |
| An efficient synthesis of aripiprazole, buspirone and NAN-190 by the reductive alkylation of amines procedure. | Archiv der Pharmazie 20120101 |
| The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease. | Parkinson's disease 20120101 |
| Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case series. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20120101 |
| Nowhere patients. | Psychotherapy and psychosomatics 20120101 |
| Lycanthropy as a culture-bound syndrome: a case report and review of the literature. | Journal of psychiatric practice 20120101 |
| A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). | Psychotherapy and psychosomatics 20120101 |
| Tinnitus: network pathophysiology-network pharmacology. | Frontiers in systems neuroscience 20120101 |
| Effect of aripiprazole on anxiety associated with ethanol physical dependence and on ethanol-induced place preference. | Journal of pharmacological sciences 20120101 |
| Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology. | Frontiers in pharmacology 20120101 |
| Aripiprazole in the acute and maintenance phase of bipolar I disorder. | Therapeutics and clinical risk management 20120101 |
| Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States. | Journal of medical economics 20120101 |
| Psychiatric symptoms of patients with primary mitochondrial DNA disorders. | Behavioral and brain functions : BBF 20120101 |
| Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties. | Patient preference and adherence 20120101 |
| Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. | BMJ (Clinical research ed.) 20120101 |
| Association between ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients. | Behavioral and brain functions : BBF 20120101 |
| Motor agency: a new and highly sensitive measure to reveal agency disturbances in early psychosis. | PloS one 20120101 |
| Antipsychotics in pediatric and adolescent patients: a review of comparative safety data. | Journal of affective disorders 20120101 |
| Aripiprazole in pediatric psychosis and bipolar disorder: a clinical review. | Journal of affective disorders 20120101 |
| Steroid-induced mania treated with aripiprazole. | Psychosomatics 20120101 |
| Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain. | PloS one 20120101 |
| Update on the role of antipsychotics in the treatment of Tourette syndrome. | Neuropsychiatric disease and treatment 20120101 |
| Serotonin toxicity in aripiprazole augmentation. | The Journal of neuropsychiatry and clinical neurosciences 20120101 |
| Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence? | BMC psychiatry 20120101 |
| Aripiprazole: polymorphs and solvatomorphs. | Profiles of drug substances, excipients, and related methodology 20120101 |
| The role of leptin in antipsychotic-induced weight gain: genetic and non-genetic factors. | Journal of obesity 20120101 |
| Psychiatric patient and anaesthesia. | Indian journal of anaesthesia 20120101 |
| Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review. | Journal of sex & marital therapy 20120101 |
| Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia. | Neuropsychiatric disease and treatment 20120101 |
| Treatment of refractory catatonic schizophrenia with low dose aripiprazole. | Annals of general psychiatry 20120101 |
| Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics. | PloS one 20120101 |
| Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice. | Evidence-based complementary and alternative medicine : eCAM 20120101 |
| Dopamine agonists and pathologic behaviors. | Parkinson's disease 20120101 |
| Critical appraisal of lurasidone in the management of schizophrenia. | Neuropsychiatric disease and treatment 20120101 |
| Hyperbaric oxygen therapy for treatment of children with autism: a systematic review of randomized trials. | Medical gas research 20120101 |
| Antidopaminergic drugs and acute pancreatitis: a population-based study. | BMJ open 20120101 |
| Sudden death of cardiac origin and psychotropic drugs. | Frontiers in pharmacology 20120101 |
| Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial. | Clinical neuropharmacology 20120101 |
| Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies. | Clinical neuropharmacology 20120101 |
| Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons. | International journal of general medicine 20120101 |
| Reduced gray to white matter tissue intensity contrast in schizophrenia. | PloS one 20120101 |
| Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia. | PloS one 20120101 |
| Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders. | Neural plasticity 20120101 |
| Typical and atypical antipsychotic drugs increase extracellular histamine levels in the rat medial prefrontal cortex: contribution of histamine h(1) receptor blockade. | Frontiers in psychiatry 20120101 |
| Unfavorable effects of hyperprolactinemia in autoimmune endocrine disorders. | Neuro endocrinology letters 20120101 |
| Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patients. | PloS one 20120101 |
| Treatment-resistant Schizophrenia: Evidence-based Strategies. | Mens sana monographs 20120101 |
| Treatment-resistant depression: therapeutic trends, challenges, and future directions. | Patient preference and adherence 20120101 |
| Successful use of add - on topiramate for antipsychotic - induced weight gain. | Indian journal of psychological medicine 20120101 |
| A case of intention tremor induced by the combination of aripiprazole and lamotrigine. | The primary care companion for CNS disorders 20120101 |
| Altered velocity processing in schizophrenia during pursuit eye tracking. | PloS one 20120101 |
| Role of aripiprazole in treatment-resistant schizophrenia. | Neuropsychiatric disease and treatment 20120101 |
| Development and validation of an LC-ESI-MS method for quantitative determination of aripiprazole in human plasma and an application to pharmacokinetic study. | Journal of chromatographic science 20120101 |
| Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug. | Annals of general psychiatry 20120101 |
| Use of aripiprazole in treatment of cannabis dependence in a patient presenting with Borderline Personality Disorder. | The Journal of neuropsychiatry and clinical neurosciences 20120101 |
| Efficacy of aripiprazole in a child with involuntary emotional expression disorder. | The Journal of neuropsychiatry and clinical neurosciences 20120101 |
| Parent report of antidepressant, anxiolytic, and antipsychotic medication use in individuals with Williams syndrome: effectiveness and adverse effects. | Research in developmental disabilities 20120101 |
| Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey. | Health and quality of life outcomes 20120101 |
| Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia. | The Annals of pharmacotherapy 20120101 |
| Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses. | Health economics review 20120101 |
| Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. | BMC psychiatry 20120101 |
| Retrospective study of Japanese patients with schizophrenia treated with aripiprazole. | ISRN nursing 20120101 |
| [Useful pharmacologic treatment in impaired social interaction in autism spectrum disorders]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20120101 |
| [Mood stabilizers in the treatment of bipolar disorder mixed states]. | Rivista di psichiatria 20120101 |
| Treatment of cerebellar cognitive affective syndrome with aripiprazole. | Journal of pediatric rehabilitation medicine 20120101 |
| Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA. | PloS one 20120101 |
| Aripiprazole reverses paliperidone-induced hyperprolactinemia. | Actas espanolas de psiquiatria 20120101 |
| High-performance liquid chromatography method using ultraviolet detection for the quantification of aripiprazole and dehydroaripiprazole in psychiatric patients. | Drug metabolism and drug interactions 20120101 |
| Efficacy of adjunctive aripiprazole in major depressive disorder: a pooled response quartile analysis and the predictive value of week 2 early response. | The primary care companion for CNS disorders 20120101 |
| Review of the safety of second-generation antipsychotics: are they really 'atypically' safe for youth and adults? | The primary care companion for CNS disorders 20120101 |
| Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors. | European journal of pharmacology 20111205 |
| Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database. | British journal of clinical pharmacology 20111201 |
| Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers. | Psychopharmacology 20111201 |
| Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior. | Psychopharmacology 20111201 |
| Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20111201 |
| A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden. | Nordic journal of psychiatry 20111201 |
| Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress. | Neuroscience research 20111201 |
| Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents. | European child & adolescent psychiatry 20111201 |
| Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance. | Current medical research and opinion 20111201 |
| Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia. | Journal of clinical psychopharmacology 20111201 |
| A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo. | Journal of clinical psychopharmacology 20111201 |
| Treatments for methamphetamine abuse: a literature review for the clinician. | Journal of pharmacy practice 20111201 |
| An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients. | Palliative & supportive care 20111201 |
| Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial. | Human psychopharmacology 20111201 |
| Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments. | Archives of general psychiatry 20111201 |
| Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. | Journal of child and adolescent psychopharmacology 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| [Perception of atypical antipsychotics' side effects through speech analysis of schizophrenic patients. TALK Study]. | L'Encephale 20111201 |
| [Guidelines for the biological treatment of bipolar depression]. | L'Encephale 20111201 |
| Sundown syndrome in persons with dementia: an update. | Psychiatry investigation 20111201 |
| Completion of chronic hepatitis C virus treatment in interferon-induced major depressive disorder with psychotic features. | Psychiatry investigation 20111201 |
| Adjunctive aripiprazole for depression: predictive value of early assessment. | The American journal of managed care 20111201 |
| A review of obsessive-compulsive disorder in children and adolescents. | Dialogues in clinical neuroscience 20111201 |
| [Misuse of alcohol and new drug treatments]. | La Revue du praticien 20111201 |
| Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. | Proceedings of the National Academy of Sciences of the United States of America 20111108 |
| Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. | Journal of psychopharmacology (Oxford, England) 20111101 |
| Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. | Psychological medicine 20111101 |
| Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents. | Neurochemistry international 20111101 |
| Manic induction with interferon alpha therapy. | The Australian and New Zealand journal of psychiatry 20111101 |
| Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment. | Expert review of neurotherapeutics 20111101 |
| An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20111101 |
| A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder. | International journal of psychiatry in clinical practice 20111101 |
| [Potentiation of Aripiprazole extrapiramidal adverse effects with the concomitant use of serotonin selective reuptake inhibitors]. | Revista medica de Chile 20111101 |
| [Eosinophilic myocarditis and sudden unexpected death in a younger patient treated with antipsychotics]. | Ugeskrift for laeger 20111031 |
| Effectiveness and safety of antipsychotics in early onset psychoses: a long-term comparison. | Psychiatry research 20111030 |
| Optimality, sample size, and power calculations for the sequential parallel comparison design. | Statistics in medicine 20111015 |
| In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors. | European journal of pharmacology 20111015 |
| An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease. | PLoS currents 20111011 |
| Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. | Lancet (London, England) 20111008 |
| Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study. | Neuroscience letters 20111003 |
| Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis. | Journal of affective disorders 20111001 |
| Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models. | The international journal of neuropsychopharmacology 20111001 |
| Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release. | Synapse (New York, N.Y.) 20111001 |
| Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats. | Pharmaceutical research 20111001 |
| Early detection and management of atypical neuroleptic malignant syndrome secondary to aripiprazole. | Schizophrenia research 20111001 |
| Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice. | Acta pharmacologica Sinica 20111001 |
| Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study. | Journal of clinical psychopharmacology 20111001 |
| Cerebral blood flow changes in very-late-onset schizophrenia-like psychosis with catatonia before and after successful treatment. | Psychiatry and clinical neurosciences 20111001 |
| Aripiprazole monotherapy in the treatment of vascular parkinsonism. | Psychiatry and clinical neurosciences 20111001 |
| Influence of prenatal undernutrition on the effects of clozapine and aripiprazole in the adult male rats: relevance to a neurodevelopmental origin of schizophrenia? | European journal of pharmacology 20110930 |
| Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring? | European journal of pharmacology 20110930 |
| Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. | JAMA 20110928 |
| Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter. | Journal of medicinal chemistry 20110922 |
| Adjunctive antipsychotics for major depression. | The Medical letter on drugs and therapeutics 20110919 |
| Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain. | Psychopharmacology 20110901 |
| The GiSAS study: rationale and design of a pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia. | Contemporary clinical trials 20110901 |
| Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder. | Acta psychiatrica Scandinavica 20110901 |
| Functional potencies of dopamine agonists and antagonists at human dopamine D₂ and D₃ receptors. | European journal of pharmacology 20110901 |
| A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). | The American journal of psychiatry 20110901 |
| CODA-RET reveals functional selectivity as a result of GPCR heteromerization. | Nature chemical biology 20110901 |
| Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study. | The Journal of clinical psychiatry 20110901 |
| Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression. | Clinical therapeutics 20110901 |
| Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis. | Schizophrenia bulletin 20110901 |
| Aripiprazole in the treatment of irritability associated with autistic disorder in paediatric patients: profile report. | CNS drugs 20110901 |
| [Clinical characteristics of cannabis-induced schizophrenia spectrum disorder]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20110901 |
| Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. | Psychiatric services (Washington, D.C.) 20110901 |
| Switching antipsychotic medications: not enough, too often, or just right? | The American journal of psychiatry 20110901 |
| Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index. | The American journal of psychiatry 20110901 |
| Antidepressant prescribing patterns in Korea: results from the clinical research center for depression study. | Psychiatry investigation 20110901 |
| Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure. | Current neuropharmacology 20110901 |
| Aripiprazole versus placebo for schizophrenia. | The Cochrane database of systematic reviews 20110810 |
| Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110801 |
| Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics. | The Journal of clinical psychiatry 20110801 |
| Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study. | Psychopharmacology 20110801 |
| Aripiprazole maintenance increases smoked cocaine self-administration in humans. | Psychopharmacology 20110801 |
| Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. | Psychopharmacology 20110801 |
| Calculating occupancy when one does not have baseline: a comparison of different options. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110801 |
| Aripiprazole associated hyponatraemia. | The Australian and New Zealand journal of psychiatry 20110801 |
| Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110801 |
| Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole. | Journal of clinical psychopharmacology 20110801 |
| Open-label trial of aripiprazole in the treatment of trichotillomania. | Journal of clinical psychopharmacology 20110801 |
| A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). | Journal of clinical psychopharmacology 20110801 |
| Changes in the metabolic parameters and QTc interval after switching from olanzapine to aripiprazole in Japanese patients with stable schizophrenia. | Journal of clinical psychopharmacology 20110801 |
| Adding aripiprazole to clozapine worsened delusions and hallucinations: a case report. | Journal of clinical psychopharmacology 20110801 |
| Aripiprazole and pregnancy: a case report and literature review. | Journal of clinical psychopharmacology 20110801 |
| A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients. | Journal of clinical psychopharmacology 20110801 |
| Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials. | Drug safety 20110801 |
| Pathological gambling and the treatment of psychosis with aripiprazole: case reports. | The British journal of psychiatry : the journal of mental science 20110801 |
| Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth. | Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20110801 |
| Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study. | Journal of child and adolescent psychopharmacology 20110801 |
| An open-label study of aripiprazole in children with a bipolar disorder. | Journal of child and adolescent psychopharmacology 20110801 |
| Relationship between P-glycoprotein and second-generation antipsychotics. | Pharmacogenomics 20110801 |
| Safety and tolerability of antipsychotic treatment in young patients with schizophrenia. | The Journal of clinical psychiatry 20110801 |
| [A multicenter controlled study on aripiprazole treatment for children with Tourette syndrome in China]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20110801 |
| Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost. | American journal of therapeutics 20110701 |
| A prospective open-label study of aripiprazole in fragile X syndrome. | Psychopharmacology 20110701 |
| Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication. | Psychopharmacology 20110701 |
| Species independence in brain tissue binding using brain homogenates. | Drug metabolism and disposition: the biological fate of chemicals 20110701 |
| Pharmacokinetics and metabolism update for some recent antipsychotics. | Expert opinion on drug metabolism & toxicology 20110701 |
| Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia. | Schizophrenia research 20110701 |
| The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone. | Progress in neuro-psychopharmacology & biological psychiatry 20110701 |
| A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level. | Progress in neuro-psychopharmacology & biological psychiatry 20110701 |
| Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats. | Naunyn-Schmiedeberg's archives of pharmacology 20110701 |
| Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia. | The Annals of pharmacotherapy 20110701 |
| Changes in weight and other metabolic indicators in persons with schizophrenia following a switch to aripiprazole. | Clinical schizophrenia & related psychoses 20110701 |
| Issues in the management of challenging behaviours of adults with autism spectrum disorder. | CNS drugs 20110701 |
| Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis. | Archives of neurology 20110701 |
| Psychosis in Parkinson's disease. | Annals of Indian Academy of Neurology 20110701 |
| Dementia in parkinsonism. | Annals of Indian Academy of Neurology 20110701 |
| Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study. | Behavioural brain research 20110620 |
| Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety. | Journal of psychopharmacology (Oxford, England) 20110601 |
| Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. | The European journal of health economics : HEPAC : health economics in prevention and care 20110601 |
| Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis. | International journal of geriatric psychiatry 20110601 |
| Aripiprazole versus haloperidol treatment in early-stage schizophrenia. | Journal of psychiatric research 20110601 |
| Antipsychotic drug use and community-acquired pneumonia. | Current infectious disease reports 20110601 |
| Placental transfer of aripiprazole. | The Australian and New Zealand journal of psychiatry 20110601 |
| Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20110601 |
| Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients. | Paediatric drugs 20110601 |
| Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. | Journal of clinical psychopharmacology 20110601 |
| Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors. | Journal of clinical psychopharmacology 20110601 |
| Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms. | Journal of clinical psychopharmacology 20110601 |
| Aripiprazole-associated leukopenia with coadministration of fluoxetine: a case report. | Journal of clinical psychopharmacology 20110601 |
| Perinatal use of aripiprazole: a case report. | Journal of clinical psychopharmacology 20110601 |
| Comment on 'dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia'. | Journal of clinical psychopharmacology 20110601 |
| Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound. | Bioorganic & medicinal chemistry 20110601 |
| Aripiprazole and haloperidol in the treatment of delirium. | The Australian and New Zealand journal of psychiatry 20110601 |
| Emerging drugs for schizophrenia. | Expert opinion on emerging drugs 20110601 |
| Adverse effects of oral nonstimulant psychotropic medications in young children reported to a regional poison center. | Clinical toxicology (Philadelphia, Pa.) 20110601 |
| The quantitative detection of aripiprazole and its main metabolite by using capillary-electrophoresis. | Journal of the Chinese Medical Association : JCMA 20110601 |
| Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study. | Journal of child and adolescent psychopharmacology 20110601 |
| Low-dose aripiprazole resolved complex hallucinations in the left visual field after right occipital infarction (Charles Bonnet syndrome). | Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society 20110601 |
| Quality of life after electroconvulsive therapy in persons with treatment resistant schizophrenia. | The Indian journal of medical research 20110601 |
| Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives. | Dialogues in clinical neuroscience 20110601 |
| Biomarkers in development of psychotropic drugs. | Dialogues in clinical neuroscience 20110601 |
| A case of catatonia and neuroleptic malignant syndrome probably associated with antipsychotic in Korea. | Psychiatry investigation 20110601 |
| [Functional homology between alcohol dependence and mood disorder]. | Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20110601 |
| Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis. | Journal of psychopharmacology (Oxford, England) 20110501 |
| Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis. | Journal of psychopharmacology (Oxford, England) 20110501 |
| Restless legs syndrome due to aripiprazole. | European journal of clinical pharmacology 20110501 |
| A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. | International clinical psychopharmacology 20110501 |
| Discovery of PF-00217830: aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder. | Bioorganic & medicinal chemistry letters 20110501 |
| An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being. | Pharmacopsychiatry 20110501 |
| A systematic review of medical treatments for children with autism spectrum disorders. | Pediatrics 20110501 |
| Role of atypical antipsychotics in rapid cycling bipolar disorder: a review of the literature. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20110501 |
| Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature. | PLoS medicine 20110501 |
| Use of aripiprazole in adolescents with a history of lupus-associated psychosis and refractory psychiatric manifestations. | Journal of psychiatric practice 20110501 |
| Psychosis in Parkinson's disease: therapeutic options. | Drugs of today (Barcelona, Spain : 1998) 20110501 |
| Fragile x syndrome. | Current genomics 20110501 |
| Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: case reports. | The International journal of eating disorders 20110401 |
| All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. | CNS neuroscience & therapeutics 20110401 |
| Routine outcomes monitoring to support improving care for schizophrenia: report from the VA Mental Health QUERI. | Community mental health journal 20110401 |
| Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder. | The Journal of clinical psychiatry 20110401 |
| Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex. | Psychopharmacology 20110401 |
| Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. | Journal of affective disorders 20110401 |
| Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations. | Clinical psychology review 20110401 |
| Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells. | Neuroscience research 20110401 |
| Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. | Schizophrenia research 20110401 |
| Aripiprazole to treat irritability associated with autism: a placebo-controlled, fixed-dose trial. | Current psychiatry reports 20110401 |
| Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. | European psychiatry : the journal of the Association of European Psychiatrists 20110401 |
| Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion. | Journal of clinical psychopharmacology 20110401 |
| Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. | Journal of clinical psychopharmacology 20110401 |
| Aripiprazole-related acute transient myopia and diplopia: a case report. | Journal of clinical psychopharmacology 20110401 |
| Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study. | Advances in therapy 20110401 |
| European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. | European child & adolescent psychiatry 20110401 |
| Effectiveness of aripiprazole for medication overuse headache: a case report. | Psychiatry and clinical neurosciences 20110401 |
| Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services. | The Journal of clinical psychiatry 20110401 |
| Newer molecules in the treatment of schizophrenia: A clinical update. | Indian journal of pharmacology 20110401 |
| Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone. | Progress in neuro-psychopharmacology & biological psychiatry 20110330 |
| Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment. | Progress in neuro-psychopharmacology & biological psychiatry 20110330 |
| A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone. | Progress in neuro-psychopharmacology & biological psychiatry 20110330 |
| A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. | Journal of medicinal chemistry 20110324 |
| Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review. | International clinical psychopharmacology 20110301 |
| Three cases of hypomania and one case of mania during aripiprazole treatment. | Pharmacopsychiatry 20110301 |
| Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders. | European child & adolescent psychiatry 20110301 |
| Aripiprazole for the treatment of irritability associated with autism. | Expert opinion on pharmacotherapy 20110301 |
| Olanzapine-induced parkinsonism associated with smoking cessation. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110301 |
| Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. | Bipolar disorders 20110301 |
| Effects of gastrodia elata bl on phencyclidine-induced schizophrenia-like psychosis in mice. | Current neuropharmacology 20110301 |
| Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs. | Schizophrenia research 20110201 |
| Tail suspension test does not detect antidepressant-like properties of atypical antipsychotics. | Behavioural pharmacology 20110201 |
| Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia. | Therapeutic drug monitoring 20110201 |
| Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study. | Current medical research and opinion 20110201 |
| Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection. | Journal of clinical psychopharmacology 20110201 |
| Micturition difficulty associated with aripiprazole: report of 2 cases. | Journal of clinical psychopharmacology 20110201 |
| Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient. | Journal of clinical psychopharmacology 20110201 |
| Potential control of risperidone-related cognitive deficits by adjunctive aripiprazole treatment. | Journal of clinical psychopharmacology 20110201 |
| Aripiprazole-induced pathological gambling: a report of 3 cases. | Current drug safety 20110201 |
| Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. | CNS drugs 20110201 |
| Aripiprazole for the treatment of bipolar disorder: a review of current evidence. | Expert opinion on pharmacotherapy 20110201 |
| Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series. | Psychiatry and clinical neurosciences 20110201 |
| Aripiprazole adjunctive to antidepressant therapy. | The American journal of psychiatry 20110201 |
| The role of serotonin receptors in the action of atypical antipsychotic drugs. | Current opinion in pharmacology 20110201 |
| Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital. | Indian journal of pharmacology 20110201 |
| Aripiprazole protects cortical neurons from glutamate toxicity. | European journal of pharmacology 20110125 |
| Management of schizophrenia in children and adolescents: focus on pharmacotherapy. | Drugs 20110122 |
| Repetitive administration of aripiprazole enhances locomotor response to methamphetamine in mice. | Behavioural brain research 20110120 |
| A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone. | Progress in neuro-psychopharmacology & biological psychiatry 20110115 |
| Aripiprazole can treat psychotic features but not motor symptoms of Parkinson's disease: evidence from a SPECT study. | Progress in neuro-psychopharmacology & biological psychiatry 20110115 |
| Worsening psychosis after adding aripiprazole to clozapine. | Progress in neuro-psychopharmacology & biological psychiatry 20110115 |
| An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20110115 |
| Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency. | Progress in neuro-psychopharmacology & biological psychiatry 20110115 |
| Aripiprazole augmentation induced hypertension in major depressive disorder: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20110115 |
| Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs. | Biological research for nursing 20110101 |
| Tardive dyskinesia and other movement disorders secondary to aripiprazole. | Movement disorders : official journal of the Movement Disorder Society 20110101 |
| Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents. | Schizophrenia research 20110101 |
| Switching to aripiprazole as a strategy for weight reduction: a meta-analysis in patients suffering from schizophrenia. | Journal of obesity 20110101 |
| Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110101 |
| Neutropenia associated with quetiapine, olanzapine, and aripiprazole. | The Australian and New Zealand journal of psychiatry 20110101 |
| Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization. | Naunyn-Schmiedeberg's archives of pharmacology 20110101 |
| Second-generation antipsychotics in major depressive disorder: update and clinical perspective. | Current opinion in psychiatry 20110101 |
| Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia. | Current medical research and opinion 20110101 |
| Psychotropic drug-related eosinophilia with systemic symptoms after acute caffeine ingestion. | Pediatrics 20110101 |
| Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole. | Addiction biology 20110101 |
| The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia. | Expert review of neurotherapeutics 20110101 |
| If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. | Drugs 20110101 |
| One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis. | BMC psychiatry 20110101 |
| Aripiprazole: striving towards euthymia with a novel mechanism of action. | Journal of affective disorders 20110101 |
| Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness. | Journal of affective disorders 20110101 |
| A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder. | Journal of affective disorders 20110101 |
| Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder. | Journal of affective disorders 20110101 |
| Risperidone versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20110101 |
| The effects of centralised and specialised combined pharmacological and psychological intervention compared with decentralised and non-specialised treatment in the early course of severe unipolar and bipolar affective disorders--design of two randomised clinical trials. | Trials 20110101 |
| Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia. | BMC psychiatry 20110101 |
| Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study. | The American journal on addictions 20110101 |
| Weight gain, obesity, and psychotropic prescribing. | Journal of obesity 20110101 |
| Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). | Movement disorders : official journal of the Movement Disorder Society 20110101 |
| Altered small-world brain networks in temporal lobe in patients with schizophrenia performing an auditory oddball task. | Frontiers in systems neuroscience 20110101 |
| Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study. | BMC gastroenterology 20110101 |
| Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia. | Internal medicine (Tokyo, Japan) 20110101 |
| Contributions to the study of morphofunctional interrelations in the liver of the rats treated with certain antipsychotic drugs. | Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 20110101 |
| Phenomenology and treatment of Catatonia: A descriptive study from north India. | Indian journal of psychiatry 20110101 |
| Class effect of pharmacotherapy in bipolar disorder: fact or misbelief? | Annals of general psychiatry 20110101 |
| Paliperidone extended-release: does it have a place in antipsychotic therapy? | Drug design, development and therapy 20110101 |
| Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium. | Annals of general psychiatry 20110101 |
| Management of Huntington's disease: role of tetrabenazine. | Therapeutics and clinical risk management 20110101 |
| Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs. | Handbook of clinical neurology 20110101 |
| L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study. | BMC medicine 20110101 |
| Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system. | Neuropharmacology 20110101 |
| Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study. | Current pharmaceutical design 20110101 |
| Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. | Current pharmaceutical design 20110101 |
| [Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder]. | Tijdschrift voor psychiatrie 20110101 |
| Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia. | Neuropsychiatric disease and treatment 20110101 |
| Pharmacotherapy for treatment-resistant schizophrenia. | Neuropsychiatric disease and treatment 20110101 |
| Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder. | Frontiers in psychiatry 20110101 |
| Anhedonia and substance dependence: clinical correlates and treatment options. | Frontiers in psychiatry 20110101 |
| AUTISM Spectrum Disorders and Suicidality. | Clinical practice and epidemiology in mental health : CP & EMH 20110101 |
| The Clinical Global Impression Scale and the influence of patient or staff perspective on outcome. | BMC psychiatry 20110101 |
| Aripiprazole augmentation in the treatment of military-related PTSD with major depression: a retrospective chart review. | BMC psychiatry 20110101 |
| Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics. | BMC psychiatry 20110101 |
| Antidepressant and antipsychotic use in an Italian pediatric population. | BMC pediatrics 20110101 |
| Postural control in bipolar disorder: increased sway area and decreased dynamical complexity. | PloS one 20110101 |
| Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine. | Frontiers in psychiatry 20110101 |
| Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia. | PloS one 20110101 |
| Combination of aripiprazole and ethanol attenuates marble-burying behavior in mice. | Acta poloniae pharmaceutica 20110101 |
| Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder. | Neuropsychiatric disease and treatment 20110101 |
| Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence. | Neuropsychiatric disease and treatment 20110101 |
| Role of sublingual asenapine in treatment of schizophrenia. | Neuropsychiatric disease and treatment 20110101 |
| Advances in understanding and treating ADHD. | BMC medicine 20110101 |
| Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. | Patient preference and adherence 20110101 |
| Aripiprazole-related body-weight gain and nutritional counseling. | The Journal of neuropsychiatry and clinical neurosciences 20110101 |
| Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study. | Clinical practice and epidemiology in mental health : CP & EMH 20110101 |
| Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review. | Journal of pharmacy & bioallied sciences 20110101 |
| Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials. | BMC psychiatry 20110101 |
| BioGraph: unsupervised biomedical knowledge discovery via automated hypothesis generation. | Genome biology 20110101 |
| A new drug design targeting the adenosinergic system for Huntington's disease. | PloS one 20110101 |
| Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose. | Current medicinal chemistry 20110101 |
| Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies. | The primary care companion for CNS disorders 20110101 |
| Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies. | The primary care companion for CNS disorders 20110101 |
| Aripiprazole in treating a manic episode associated with hydrocephalus: a case report. | The primary care companion for CNS disorders 20110101 |
| Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs. | Frontiers in behavioral neuroscience 20110101 |
| Clinical potential of lurasidone in the management of schizophrenia. | Therapeutics and clinical risk management 20110101 |
| Treatment dilemma in comorbidity of schizophrenia and idiopathic Parkinson's disease. | General hospital psychiatry 20110101 |
| Is the PANSS used correctly? a systematic review. | BMC psychiatry 20110101 |
| Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy. | Clinical neuropharmacology 20110101 |
| Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCD. | Clinical neuropharmacology 20110101 |
| Successful use of aripiprazole for delusional disorder with comorbid pituitary microadenoma: a case report. | Psychosomatics 20110101 |
| [Lithium and anticonvulsants in the treatment of mania and in the prophylaxis of recurrences]. | Rivista di psichiatria 20110101 |
| Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder. | Patient preference and adherence 20110101 |
| Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia. | BMC psychiatry 20110101 |
| The effect of repetitive transcranial magnetic stimulation on gamma oscillatory activity in schizophrenia. | PloS one 20110101 |
| Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability. | Depression research and treatment 20110101 |
| Acute hypersensitivity syndrome caused by valproic Acid: a review of the literature and a case report. | The Permanente journal 20110101 |
| A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers. | PloS one 20110101 |
| Priapism due to a single dose of quetiapine: a case report. | Turk psikiyatri dergisi = Turkish journal of psychiatry 20110101 |
| A Data-Driven Investigation of Gray Matter-Function Correlations in Schizophrenia during a Working Memory Task. | Frontiers in human neuroscience 20110101 |
| Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia. | Frontiers in neuroanatomy 20110101 |
| Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms. | Frontiers in neuroscience 20110101 |
| Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy. | ClinicoEconomics and outcomes research : CEOR 20110101 |
| A case of bilateral self-induced keratoconus in a patient with tourette syndrome associated with compulsive eye rubbing: case report. | BMC ophthalmology 20110101 |
| Improvement of oral dyskinesia after switching from aripiprazole to paliperidone: a case report. | The Journal of neuropsychiatry and clinical neurosciences 20110101 |
| Aripiprazole-associated rhabdomyolysis in a patient with schizophrenia. | The Journal of neuropsychiatry and clinical neurosciences 20110101 |
| Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder. | Journal of medical economics 20110101 |
| Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines. | The primary care companion for CNS disorders 20110101 |
| Altered topological properties of functional network connectivity in schizophrenia during resting state: a small-world brain network study. | PloS one 20110101 |
| Alternating hemiplegia in a child misdiagnosed as intractable epilepsy successfully treated with aripiprazole: a case report. | West African journal of medicine 20110101 |
| [Rapid tranquillisation; review of the literature and recommendations]. | Tijdschrift voor psychiatrie 20110101 |
| Autism spectrum disorders and schizophrenia: meta-analysis of the neural correlates of social cognition. | PloS one 20110101 |
| Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. | Pharmacological reports : PR 20110101 |
| The management of schizophrenia: focus on extended-release quetiapine fumarate. | Neuropsychiatric disease and treatment 20110101 |
| Current management of obsessive and phobic states. | Neuropsychiatric disease and treatment 20110101 |
| [Delusional parasitosis associated with dialysis treated with aripiprazole]. | Acta medica portuguesa 20110101 |
| Management of bipolar depression. | Indian journal of psychological medicine 20110101 |
| Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital. | Indian journal of psychological medicine 20110101 |
| Inverse agonism and its therapeutic significance. | Indian journal of pharmacology 20110101 |
| Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission. | Frontiers in molecular neuroscience 20110101 |
| Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. | Frontiers in molecular neuroscience 20110101 |
| Pituitary microadenoma treated with antipsychotic drug aripiprazole. | Recent patents on endocrine, metabolic & immune drug discovery 20110101 |
| The treatment of severe child aggression (TOSCA) study: Design challenges. | Child and adolescent psychiatry and mental health 20110101 |
| Clinical utility of the risperidone formulations in the management of schizophrenia. | Neuropsychiatric disease and treatment 20110101 |
| Supervised team management, with or without structured psychotherapy, in heavy users of a mental health service with borderline personality disorder: a two-year follow-up preliminary randomized study. | BMC psychiatry 20110101 |
| Aripiprazole improves olanzapine-associated obsessive compulsive symptoms in schizophrenia. | Clinical neuropharmacology 20110101 |
| The efficacy of low-dose aripiprazole treatment for trichotillomania. | Clinical neuropharmacology 20110101 |
| Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study. | BMC medical research methodology 20110101 |
| Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians. | Patient preference and adherence 20110101 |
| [Evidence of treatment for depressive episodes of bipolar disorder]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20110101 |
| Resting-state EEG source localization and functional connectivity in schizophrenia-like psychosis of epilepsy. | PloS one 20110101 |
| Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder. | Neuropsychiatric disease and treatment 20110101 |
| Visible spectrophotometric method for the determination of aripiprazole in tablets. | Indian journal of pharmaceutical sciences 20110101 |
| Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports. | Turk psikiyatri dergisi = Turkish journal of psychiatry 20110101 |
| The dopamine hypothesis of drug addiction and its potential therapeutic value. | Frontiers in psychiatry 20110101 |
| Identification of major degradation products of ketoconazole. | Scientia pharmaceutica 20110101 |
| Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. | PloS one 20110101 |
| Antidepressant drug exposure during pregnancy. CZTIS small prospective study. | Neuro endocrinology letters 20110101 |
| Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose? | BMC psychiatry 20110101 |
| Delusional infestation in a patient with renal failure, metabolic syndrome, and chronic cerebrovascular disease treated with aripiprazole: a case report. | Case reports in medicine 20110101 |
| Use of antipsychotic and antidepressant within the Psychiatric Disease Centre, Regional Health Service of Ferrara. | BMC clinical pharmacology 20110101 |
| Sexual dysfunction and hyperprolactinemia in male psychotic inpatients: a cross-sectional study. | Advances in urology 20110101 |
| Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. | Frontiers in psychiatry 20110101 |
| Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings. | Frontiers in psychiatry 20110101 |
| A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population. | PloS one 20110101 |
| Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics. | Patient preference and adherence 20110101 |
| Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan. | Patient preference and adherence 20110101 |
| Modular Organization of Functional Network Connectivity in Healthy Controls and Patients with Schizophrenia during the Resting State. | Frontiers in systems neuroscience 20110101 |
| Analysis of Adverse Drug Reactions of Atypical Antipsychotic Drugs in Psychiatry OPD. | Indian journal of psychological medicine 20110101 |
| A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole. | The primary care companion for CNS disorders 20110101 |
| A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder. | The primary care companion for CNS disorders 20110101 |
| Impulse control loss rapidly reversed by aripiprazole in a patient with concomitant bipolar disease type I and posttraumatic frontal lobe lesions. | BMJ case reports 20110101 |
| Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. | BMJ case reports 20110101 |
| A Chromatographic Determination of Aripiprazole using HPLC and UPLC: A Comparative Validation Study. | Indian journal of pharmaceutical sciences 20110101 |
| [Hyperprolactinemia in mentally ill patients]. | Acta medica portuguesa 20110101 |
| Addition of aripiprazole to the clozapine may be useful in reducing anxiety in treatment-resistant schizophrenia. | Case reports in psychiatry 20110101 |
| Delusional parasitosis of face in a factory worker. | Industrial psychiatry journal 20110101 |
| An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. | Human psychopharmacology 20110101 |
| Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems. | The Cochrane database of systematic reviews 20101208 |
| Second-generation antipsychotics for major depressive disorder and dysthymia. | The Cochrane database of systematic reviews 20101208 |
| Compliance with atypical antipsychotic triage guidelines by Texas poison centers. | Journal of medical toxicology : official journal of the American College of Medical Toxicology 20101201 |
| No alterations of brain GABA after 6 months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20101201 |
| Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics. | Progress in neuro-psychopharmacology & biological psychiatry 20101201 |
| The effect of coadministration of duloxetine on steady-state serum concentration of risperidone and aripiprazole: a study based on therapeutic drug monitoring data. | Therapeutic drug monitoring 20101201 |
| Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials. | Journal of clinical psychopharmacology 20101201 |
| Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder. | Journal of clinical psychopharmacology 20101201 |
| Therapeutic potential of new second generation antipsychotics for major depressive disorder. | Expert opinion on investigational drugs 20101201 |
| Aripiprazole as a viable alternative for treating delusions of parasitosis. | Journal of drugs in dermatology : JDD 20101201 |
| New-onset psychosis and emergence of suicidal ideation with aripiprazole. | The American journal of psychiatry 20101201 |
| Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting. | Assay and drug development technologies 20101201 |
| Temporomandibular dislocation due to aripiprazole induced dystonia. | British journal of clinical pharmacology 20101201 |
| Pharmacotherapeutics of Tourette syndrome and stereotypies in autism. | Seminars in pediatric neurology 20101201 |
| Acute akathisia with quetiapine: A case report and review of literature. | Indian journal of pharmacology 20101201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20101201 |
| Deficits in facial emotion recognition in schizophrenia: a replication study with korean subjects. | Psychiatry investigation 20101201 |
| Brain serotonergic circuitries. | Dialogues in clinical neuroscience 20101201 |
| Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | Healthcare informatics research 20101201 |
| Successful drug development despite adverse preclinical findings part 2: examples. | Journal of toxicologic pathology 20101201 |
| Antipsychotic drugs dose-dependently suppress the spontaneous hyperactivity of the chakragati mouse. | Neuroscience 20101124 |
| Partial agonist therapy in schizophrenia: relevance to diminished criminal responsibility. | Journal of forensic sciences 20101101 |
| A systematic review of aripiprazole--dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring. | The Journal of clinical psychiatry 20101101 |
| Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice. | Neuropharmacology 20101101 |
| Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. | Schizophrenia research 20101101 |
| A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007). | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101101 |
| Advances in the treatment of psychiatric disorders in long-term care homes. | Current opinion in psychiatry 20101101 |
| Treatment of tics and tourette syndrome. | Current treatment options in neurology 20101101 |
| Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. | Current treatment options in neurology 20101101 |
| Epidemiologic study of aripiprazole use and the incidence of suicide events. | Pharmacoepidemiology and drug safety 20101101 |
| Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir. | The Annals of pharmacotherapy 20101101 |
| A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies. | Journal of separation science 20101101 |
| Use of aripiprazole in a patient with multiple sclerosis presenting with paranoid psychosis. | Journal of psychiatric practice 20101101 |
| Management of a patient with schizophrenia and underlying pituitary macroadenoma. | Annals of the Academy of Medicine, Singapore 20101101 |
| Quetiapine in the treatment of psychosis in Parkinson's disease. | Therapeutic advances in neurological disorders 20101101 |
| A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia. | Psychiatry (Edgmont (Pa. : Township)) 20101101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20101101 |
| The cost-effectiveness of aripiprazole as adjunctive therapy in major depressive disorder: Thai economic model. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20101101 |
| Neuroleptic malignant syndrome with aripiprazole in Huntington's disease. | Movement disorders : official journal of the Movement Disorder Society 20101030 |
| RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). | CNS neuroscience & therapeutics 20101001 |
| Patients with schizophrenia show deficits of working memory maintenance components in circuit-specific tasks. | European archives of psychiatry and clinical neuroscience 20101001 |
| Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature. | Archives of women's mental health 20101001 |
| The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis. | The Journal of clinical psychiatry 20101001 |
| Delusional infestation: neural correlates and antipsychotic therapy investigated by multimodal neuroimaging. | Progress in neuro-psychopharmacology & biological psychiatry 20101001 |
| A case of Cotard's Syndrome successfully treated with aripiprazole monotherapy. | Progress in neuro-psychopharmacology & biological psychiatry 20101001 |
| Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD. | Progress in neuro-psychopharmacology & biological psychiatry 20101001 |
| Adjunctive treatment with low-dosage aripiprazole for blonanserin-induced hyperprolactinemia in a female patient with schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20101001 |
| Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials. | Psychopharmacology 20101001 |
| Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics. | Psychopharmacology 20101001 |
| Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase. | Journal of neural transmission (Vienna, Austria : 1996) 20101001 |
| Olanzapine abuse was relieved after switching to aripiprazole in a patient with psychotic depression. | Progress in neuro-psychopharmacology & biological psychiatry 20101001 |
| 6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics. | Bioorganic & medicinal chemistry letters 20101001 |
| Treatment options for bipolar depression: a systematic review of randomized, controlled trials. | Journal of clinical psychopharmacology 20101001 |
| Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. | Journal of clinical psychopharmacology 20101001 |
| Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010). | Journal of clinical psychopharmacology 20101001 |
| Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. | Neurocase 20101001 |
| Prolonged catatonic stupor successfully treated with aripiprazole in an adolescent male with schizophrenia: a case report. | Clinical schizophrenia & related psychoses 20101001 |
| Treatment with antipsychotics and the risk of diabetes in clinical practice. | The British journal of psychiatry : the journal of mental science 20101001 |
| Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. | Journal of child and adolescent psychopharmacology 20101001 |
| Novel 7-phenylsulfanyl-1,2,3,4,10,10a-hexahydro-pyrazino[1,2-a]indoles as dual serotonin 5-HT2C and 5-HT6 receptor ligands. | Bioorganic & medicinal chemistry letters 20100915 |
| Protective effect of aripiprazole against glutamate cytotoxicity in dopaminergic neurons of rat mesencephalic cultures. | Neuroscience letters 20100906 |
| Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial. | The international journal of neuropsychopharmacology 20100901 |
| Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. | The Journal of clinical psychiatry 20100901 |
| Self-injurious behaviour in people with intellectual disability. | Current opinion in psychiatry 20100901 |
| Treatment of Irritability in Huntington's Disease. | Current treatment options in neurology 20100901 |
| The need for a long-term perspective in child and adolescent psychiatry. | European child & adolescent psychiatry 20100901 |
| Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder. | Pharmacotherapy 20100901 |
| Management of neuropsychiatric symptoms in people with dementia. | CNS drugs 20100901 |
| Efficacy and tolerability of aripiprazole: a 26-week switching study from oral antipsychotics. | Psychiatry investigation 20100901 |
| Retrospective case series of aripiprazole augmentation in pervasive developmental disorders. | Psychiatry investigation 20100901 |
| Pharmacologic treatment of schizophrenia. | Dialogues in clinical neuroscience 20100901 |
| Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later. | Dialogues in clinical neuroscience 20100901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100901 |
| Antiepileptic drug interactions - principles and clinical implications. | Current neuropharmacology 20100901 |
| Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. | European journal of pharmacology 20100825 |
| Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| Aripiprazole monotherapy in a patient with major depressive disorder. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| Treatment of schizophreniform disorder by aripiprazole in a female adolescent with 22q11.2 deletion syndrome. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| Aripiprazole attenuates established behavioral sensitization induced by methamphetamine. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| Delusional parasitosis in a patient with brain atrophy and renal failure treated with aripiprazole: case report. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride. | Synapse (New York, N.Y.) 20100801 |
| Aripiprazole add-on treatment in a patient with schizoaffective disorder: neurocognitive outcomes. | Pharmacopsychiatry 20100801 |
| Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100801 |
| The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. | Journal of clinical psychopharmacology 20100801 |
| Long-term treatment with aripiprazole on the waking and postprandial urges to smoke in Chinese heavy smokers. | Journal of clinical psychopharmacology 20100801 |
| Aripiprazole-related subcortical growth in a patient with major depressive disorder and panic disorder. | Journal of clinical psychopharmacology 20100801 |
| What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity? | Journal of clinical psychopharmacology 20100801 |
| Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100801 |
| Simultaneous determination of aripiprazole and its active metabolite, dehydroaripiprazole, in plasma by capillary electrophoresis combining on-column field-amplified sample injection and application in schizophrenia. | Electrophoresis 20100801 |
| Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China. | Journal of child and adolescent psychopharmacology 20100801 |
| Management of hallucinations and psychosis in Parkinson's disease. | The American journal of geriatric pharmacotherapy 20100801 |
| Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole. | Psychiatry research 20100730 |
| Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. | Journal of psychopharmacology (Oxford, England) 20100701 |
| Pharmacotherapy of bipolar disorder in children and adolescents: recent progress. | CNS drugs 20100701 |
| The impact of perfectionism and anxiety traits on action monitoring in major depressive disorder. | Journal of neural transmission (Vienna, Austria : 1996) 20100701 |
| Atypical antipsychotic metabolism and excretion. | Current drug metabolism 20100701 |
| Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia. | Schizophrenia research 20100701 |
| The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives. | Current opinion in investigational drugs (London, England : 2000) 20100701 |
| Cariprazine, an orally active D2/D3 receptor antagonist, for the potential treatment of schizophrenia, bipolar mania and depression. | Current opinion in investigational drugs (London, England : 2000) 20100701 |
| Diabetic ketoacidosis and elevated serum lipase in the setting of aripiprazole therapy. | Diabetes care 20100701 |
| [Aripiprazole - a medical treatment alternative for Tourette Syndrome in childhood and adolescence]. | Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20100701 |
| Aripiprazole in autism spectrum disorders and fragile X syndrome. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20100701 |
| Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed. | Postgraduate medicine 20100701 |
| Real-world Data on Atypical Antipsychotic Medication Side Effects. | Psychiatry (Edgmont (Pa. : Township)) 20100701 |
| Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D(3) and serotonin 5-HT(1A) and 5-HT(2A) receptors. | Journal of medicinal chemistry 20100624 |
| Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents. | Journal of psychiatric research 20100601 |
| Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. | CNS neuroscience & therapeutics 20100601 |
| Hyperprolactinaemia during treatment with paliperidone. | Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20100601 |
| Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. | Current medical research and opinion 20100601 |
| A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole. | Journal of clinical psychopharmacology 20100601 |
| Clozapine-associated cerebral venous thrombosis. | Journal of clinical psychopharmacology 20100601 |
| Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia. | International journal of clinical pharmacology and therapeutics 20100601 |
| Differences of clinical characteristics and phenotypes between prepubertal- and adolescent-onset bipolar disorders. | Journal of Korean medical science 20100601 |
| Antipsychotic dosing: still a work in progress. | The American journal of psychiatry 20100601 |
| Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia. | American family physician 20100601 |
| The contribution of abdominal obesity and dyslipidemia to metabolic syndrome in psychiatric patients. | The Korean journal of internal medicine 20100601 |
| [A control study of aripiprazole and tiapride treatment for tic disorders in children]. | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20100601 |
| Changes in values of cholesterol and tryglicerides after weight loss during treatment with aripiprazole in a patient with schizophrenia - Case report. | Psychiatria Danubina 20100601 |
| Pharmacological approaches to methamphetamine dependence: a focused review. | British journal of clinical pharmacology 20100601 |
| Predictive factors of social functioning in patients with schizophrenia: exploration for the best combination of variables using data mining. | Psychiatry investigation 20100601 |
| Antipsychotic effects of quetiapine in naturalistic long term follow up study. | Psychiatry investigation 20100601 |
| Case of tardive dystonia improved by aripiprazole. | Psychiatry and clinical neurosciences 20100601 |
| [Long-term (prophylactic) therapy of bipolar patients with aripiprazole]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20100601 |
| [Use of aripiprazole in the treatment of catatonia]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20100601 |
| [Metabolic side effects of risperidone in early onset schizophrenia]. | L'Encephale 20100601 |
| Drug treatment of obsessive-compulsive disorder. | Dialogues in clinical neuroscience 20100601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100601 |
| Aripiprazole for the treatment of adolescent Tourette's syndrome: a case report. | Journal of pharmacy practice 20100601 |
| Drug-induced Pisa syndrome associated with aripiprazole during clozapine treatment. | Progress in neuro-psychopharmacology & biological psychiatry 20100530 |
| Aripiprazole augmentation for the treatment of an adolescent with posttraumatic stress disorder. | Progress in neuro-psychopharmacology & biological psychiatry 20100530 |
| Treatment of tardive dyskinesia with aripiprazole. | Neurotoxicity research 20100501 |
| Aripiprazole-induced behavioural disturbance related to impulse control in a clinical setting. | The international journal of neuropsychopharmacology 20100501 |
| Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania. | The international journal of neuropsychopharmacology 20100501 |
| The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior. | Behavioural brain research 20100501 |
| Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation. | Schizophrenia research 20100501 |
| Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes. | Naunyn-Schmiedeberg's archives of pharmacology 20100501 |
| Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats. | Journal of neural transmission (Vienna, Austria : 1996) 20100501 |
| Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression. | Expert review of neurotherapeutics 20100501 |
| Tardive dystonia due to aripiprazole use in a neuroleptic-naive patient. | The Journal of clinical psychiatry 20100501 |
| Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia. | Clinical neuropharmacology 20100501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100501 |
| Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews. | Sao Paulo medical journal = Revista paulista de medicina 20100501 |
| Review: is aripiprazole as effective as risperidone in people with schizophrenia? | Evidence-based mental health 20100501 |
| Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions. | Toxicology 20100411 |
| The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder. | Journal of psychopharmacology (Oxford, England) 20100401 |
| Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. | The Journal of pharmacology and experimental therapeutics 20100401 |
| Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia. | Psychopharmacology 20100401 |
| Symptomatic bradycardia with oral aripiprazole and oral ziprasidone. | The Annals of pharmacotherapy 20100401 |
| Restless leg syndrome associated with olanzapine: a case series. | Current drug safety 20100401 |
| Rapid response to antipsychotic treatment on psychotic prodrome: implications from a case series. | Psychiatry and clinical neurosciences 20100401 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100401 |
| [Action of amygdala dopamine and effect of antipsychotics]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20100401 |
| First manic episode in a 55-year-old man after initiation of aripiprazole. | Psychiatry (Edgmont (Pa. : Township)) 20100401 |
| Aripiprazole in pregnancy and lactation: a case report. | Journal of clinical psychopharmacology 20100401 |
| Dopamine D2 receptors as treatment targets in schizophrenia. | Clinical schizophrenia & related psychoses 20100401 |
| Switching and combining antipsychotics. | CNS spectrums 20100401 |
| Advances in the pharmacological management of Huntington's disease. | Drugs 20100326 |
| Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16). | Journal of medicinal chemistry 20100325 |
| Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. | Progress in neuro-psychopharmacology & biological psychiatry 20100317 |
| Neuroleptic malignant syndrome with the addition of aripiprazole to clozapine. | Progress in neuro-psychopharmacology & biological psychiatry 20100317 |
| The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure. | Bioorganic & medicinal chemistry letters 20100315 |
| Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: evidence for the involvement of sympathetic regulation. | Schizophrenia bulletin 20100301 |
| Aripiprazole-induced rabbit syndrome: a case report. | Journal of psychopharmacology (Oxford, England) 20100301 |
| Somatosensory system deficits in schizophrenia revealed by MEG during a median-nerve oddball task. | Brain topography 20100301 |
| Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia. | Pharmacology, biochemistry, and behavior 20100301 |
| The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia. | Human psychopharmacology 20100301 |
| Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics. | Journal of neurochemistry 20100301 |
| The risk of death among adult participants in trials of antipsychotic drugs in schizophrenia. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100301 |
| Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors. | Bioorganic & medicinal chemistry 20100301 |
| Pathological gambling and compulsive eating associated with aripiprazole. | The Australian and New Zealand journal of psychiatry 20100301 |
| Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone. | Human psychopharmacology 20100301 |
| Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. | Human psychopharmacology 20100301 |
| Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. | Human psychopharmacology 20100301 |
| Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence. | CNS & neurological disorders drug targets 20100301 |
| Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance Study. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301 |
| Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301 |
| Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301 |
| [Difficulties in changing drugs--from clozapine to aripiprazole in ambulatory care]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20100301 |
| Aripiprazole-induced gray matter growth in a patient with major depressive disorder with panic disorder. | The Journal of clinical psychiatry 20100301 |
| Effect of aripiprazole on cognition in the treatment of patients with schizophrenia. | Pharmacopsychiatry 20100301 |
| Psychiatric pharmacogenomic testing in clinical practice. | Dialogues in clinical neuroscience 20100301 |
| Systematic reviews of assessment measures and pharmacologic treatments for agitation. | Clinical therapeutics 20100301 |
| Warning on treating depression. | Medicine and health, Rhode Island 20100301 |
| Antipsychotics in pregnancy. | Journal of psychiatric and mental health nursing 20100301 |
| Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway. | Neuroscience letters 20100226 |
| Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study. | Journal of affective disorders 20100201 |
| Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. | The international journal of neuropsychopharmacology 20100201 |
| Serious generalized tonic-clonic seizures induced by aripiprazole. | Progress in neuro-psychopharmacology & biological psychiatry 20100201 |
| Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance. | Current opinion in pharmacology 20100201 |
| Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study. | Psychiatry and clinical neurosciences 20100201 |
| Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse. | Psychopharmacology 20100201 |
| Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. | Journal of clinical psychopharmacology 20100201 |
| Aripiprazole induced acute dystonia after discontinuation of a stimulant medication. | Journal of clinical psychopharmacology 20100201 |
| Treatment with aripiprazole for hyperprolactinemia induced by pituitary microadenoma in a bipolar I disorder patient. | Journal of clinical psychopharmacology 20100201 |
| Therapeutic options for treatment-resistant depression. | CNS drugs 20100201 |
| Use of aripiprazole in clozapine induced enuresis: report of two cases. | Journal of Korean medical science 20100201 |
| Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. | Psychiatric services (Washington, D.C.) 20100201 |
| Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data. | Journal of child and adolescent psychopharmacology 20100201 |
| Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study. | Early intervention in psychiatry 20100201 |
| Trial of aripiprazole in the treatment of first-episode schizophrenia. | Psychiatry and clinical neurosciences 20100201 |
| Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia. | Psychiatry and clinical neurosciences 20100201 |
| Aripiprazole for olanzapine-induced symptomatic hyper prolactinemia. | Indian journal of pharmacology 20100201 |
| Zotepine versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100120 |
| Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss. | NeuroImage 20100101 |
| Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies. | Journal of affective disorders 20100101 |
| The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100101 |
| WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity. | The Journal of pharmacology and experimental therapeutics 20100101 |
| Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100101 |
| No influence of FAT polymorphisms in response to aripiprazole. | Journal of human genetics 20100101 |
| Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? | Current pharmaceutical design 20100101 |
| Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms. | Pharmacology & therapeutics 20100101 |
| Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. | The British journal of psychiatry : the journal of mental science 20100101 |
| Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. | Archives of general psychiatry 20100101 |
| Amisulpride versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100101 |
| Quetiapine versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100101 |
| Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. | PloS one 20100101 |
| The role of aripiprazole in Canada: A review of clinical and drug discontinuation data. Foreword. | Clinical therapeutics 20100101 |
| Aripiprazole in schizophrenia and schizoaffective disorder: A review. | Clinical therapeutics 20100101 |
| Aripiprazole for the maintenance treatment of bipolar I disorder: A review. | Clinical therapeutics 20100101 |
| Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study. | Clinical drug investigation 20100101 |
| Aripiprazole, hypertension, and confusion. | The Journal of neuropsychiatry and clinical neurosciences 20100101 |
| First-generation vs second-generation antipsychotic drugs: The ongoing saga. | Indian journal of psychiatry 20100101 |
| [Disappearance of paroxysmal perceptual alteration by switching to aripiprazole in a schizophrenic patient]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20100101 |
| Identification of molecular targets associated with ethanol toxicity and implications in drug development. | Current pharmaceutical design 20100101 |
| Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors. | Annals of general psychiatry 20100101 |
| Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. | PloS one 20100101 |
| Second-generation antipsychotics cause weight gain in youths. | The Harvard mental health letter 20100101 |
| Controversies concerning the diagnosis and treatment of bipolar disorder in children. | Child and adolescent psychiatry and mental health 20100101 |
| Olanzapine versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100101 |
| The successful treatment of disinhibition due to a possible case of non-human immunodeficiency virus neurosyphilis: a proposed pathophysiological explanation of the symptoms and treatment. | General hospital psychiatry 20100101 |
| Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism. | Neuropsychiatric disease and treatment 20100101 |
| Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole. | Neuropsychiatric disease and treatment 20100101 |
| New atypical antipsychotics for schizophrenia: iloperidone. | Drug design, development and therapy 20100101 |
| Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression. | Case reports in medicine 20100101 |
| Optimization of aripiprazole synthesis. | Acta poloniae pharmaceutica 20100101 |
| Tetrabenazine is neuroprotective in Huntington's disease mice. | Molecular neurodegeneration 20100101 |
| Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder. | Chang Gung medical journal 20100101 |
| Medications acting on the dopaminergic system in the treatment of alcoholic patients. | Current pharmaceutical design 20100101 |
| Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine. | PloS one 20100101 |
| Middle and Late Latency ERP Components Discriminate between Adults, Typical Children, and Children with Sensory Processing Disorders. | Frontiers in integrative neuroscience 20100101 |
| Anticholinergic use in children and adolescents after initiation of antipsychotic therapy. | The Annals of pharmacotherapy 20100101 |
| Pharmacotherapy and the risk for community-acquired pneumonia. | BMC geriatrics 20100101 |
| Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder. | PharmacoEconomics 20100101 |
| S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance. | Cardiovascular psychiatry and neurology 20100101 |
| Comments on 'Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials'. | General hospital psychiatry 20100101 |
| Augmentation of clozapine with aripiprazole in severe psychotic bipolar and schizoaffective disorders: a pilot study. | Clinical practice and epidemiology in mental health : CP & EMH 20100101 |
| Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy. | Frontiers in neuroscience 20100101 |
| Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease. | The Journal of neuropsychiatry and clinical neurosciences 20100101 |
| Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder. | Clinical drug investigation 20100101 |
| Factors associated with dental caries among institutionalized residents with schizophrenia in Taiwan: a cross-sectional study. | BMC public health 20100101 |
| Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders. | BMC psychiatry 20100101 |
| Clinical pharmacology and vascular risk. | The open neurology journal 20100101 |
| Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report. | BMC psychiatry 20100101 |
| No influence of DTNBP1 polymorphisms on the response to aripiprazole. | Neuropsychobiology 20100101 |
| Lithium, trifluperazine and idiopathic leucopenia: Author and reviewer perspectives on how to write a good case report. | Indian journal of psychiatry 20100101 |
| A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting. | Annals of general psychiatry 20100101 |
| Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder. | General hospital psychiatry 20100101 |
| Aripiprazole for late-life schizophrenia. | Clinical interventions in aging 20100101 |
| Getting the balance right: Established and emerging therapies for major depressive disorders. | Neuropsychiatric disease and treatment 20100101 |
| Emerging role of sertindole in the management of schizophrenia. | Neuropsychiatric disease and treatment 20100101 |
| Emerging treatments in the management of bipolar disorder - focus on risperidone long acting injection. | Neuropsychiatric disease and treatment 20100101 |
| Emerging treatments in the management of schizophrenia - focus on sertindole. | Drug design, development and therapy 20100101 |
| Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse. | Neuropsychiatric disease and treatment 20100101 |
| Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence. | Patient preference and adherence 20100101 |
| Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection. | Patient preference and adherence 20100101 |
| Acyclovir nephrotoxicity: a case report highlighting the importance of prevention, detection, and treatment of acyclovir-induced nephropathy. | Case reports in medicine 20100101 |
| Hyperprolactinemia with antipsychotic drugs in children and adolescents. | International journal of pediatric endocrinology 20100101 |
| Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula. | BMC psychiatry 20100101 |
| Exploratory analysis of psychiatric-related utilization and costs associated with paliperidone ER compared with other oral atypical antipsychotics using pharmacy claims from an administrative database. | Journal of medical economics 20100101 |
| Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group. | Clinical drug investigation 20100101 |
| Zotepine versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100101 |
| Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole. | Actas espanolas de psiquiatria 20100101 |
| Pharmaceutical treatment of acute bipolar depression. | F1000 medicine reports 20100101 |
| Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension. | Neuropsychiatric disease and treatment 20100101 |
| Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. | Neuropsychiatric disease and treatment 20100101 |
| Role of paliperidone extended-release in treatment of schizoaffective disorder. | Neuropsychiatric disease and treatment 20100101 |
| Aripiprazole treatment for coprophagia in autistic disorder. | The Journal of neuropsychiatry and clinical neurosciences 20100101 |
| Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder. | BMC psychiatry 20100101 |
| Patient perspectives on antipsychotic treatments and their association with clinical outcomes. | Patient preference and adherence 20100101 |
| Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet. | Psychosomatics 20100101 |
| Choreoathetosis in the setting of lithium toxicity. | Psychosomatics 20100101 |
| Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies. | Psychopharmacology bulletin 20100101 |
| Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials. | Psychopharmacology bulletin 20100101 |
| Clozapine versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100101 |
| New insights in the management of antipsychotics in the treatment of schizophrenia in a patient with prolactinoma: a case report and review of the literature. | Case reports in medicine 20100101 |
| Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients. | Neuropsychiatric disease and treatment 20100101 |
| Off-label second generation antipsychotics for impulse regulation disorders: a review. | Psychopharmacology bulletin 20100101 |
| Prescription drugs associated with reports of violence towards others. | PloS one 20100101 |
| [The quest for the pharmacological treatment of schizophrenia: from conventional neuroleptics to atypical antipsychotics and beyond]. | Vertex (Buenos Aires, Argentina) 20100101 |
| Efficacy of high-dose aripiprazole for treatment-resistant schizoaffective disorder: a case report. | Psychopharmacology bulletin 20100101 |
| A Case of Treatment Resistant Depression and Alcohol Abuse in a Person with Mental Retardation: Response to Aripiprazole and Fluvoxamine Therapy upon Consideration of a Bipolar Diathesis after Repetitive Failure to Respond to Multiple Antidepressant Trials. | Case reports in medicine 20100101 |
| The geriatric population and psychiatric medication. | Mens sana monographs 20100101 |
| Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management. | Mens sana monographs 20100101 |
| [Efficacy of aripiprazole on patients with at-risk mental state and subjective well-being]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20100101 |
| Safety and tolerability of antipsychotics: focus on amisulpride. | Drug, healthcare and patient safety 20100101 |
| Asenapine, a new sublingual atypical antipsychotic. | Journal of pharmacology & pharmacotherapeutics 20100101 |
| An overview of Indian research in schizophrenia. | Indian journal of psychiatry 20100101 |
| Research on antipsychotics in India. | Indian journal of psychiatry 20100101 |
| Incontinence and mood disorder: is there an association? | BMJ case reports 20100101 |
| The effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brain. | Neuroscience 20091229 |
| Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS. | Journal of pharmaceutical and biomedical analysis 20091205 |
| Very high-dose clozapine and electroconvulsive therapy combination treatment in a patient with schizophrenia. | The journal of ECT 20091201 |
| Differential expression of glutamate transporter genes after chronic oral treatment with aripiprazole in rats. | Neurochemistry international 20091201 |
| In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268). | The Journal of pharmacology and experimental therapeutics 20091201 |
| Duration of pharmacotherapy with long-acting injectable risperidone in the treatment of schizophrenia. | The Psychiatric quarterly 20091201 |
| Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse. | Psychopharmacology 20091201 |
| Antipsychotic effects on auditory sensory gating in schizophrenia patients. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20091201 |
| Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. | Journal of the American Academy of Child and Adolescent Psychiatry 20091201 |
| Successful aripiprazole augmentation in a child with drug-resistant obsessive-compulsive disorder. | Journal of clinical psychopharmacology 20091201 |
| Myxedema coma associated with combination aripiprazole and sertraline therapy. | The Annals of pharmacotherapy 20091201 |
| Improvement in social competence in patients with schizophrenia: a pilot study using a performance-based measure using virtual reality. | Human psychopharmacology 20091201 |
| Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. | Pediatrics 20091201 |
| Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review. | CNS drugs 20091201 |
| Pediatric bipolar disorder. | Journal of psychosocial nursing and mental health services 20091201 |
| Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents. | Prescrire international 20091201 |
| Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study. | Journal of child and adolescent psychopharmacology 20091201 |
| [Aripiprazole-induced stuttering treated with risperidone]. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20091201 |
| The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey. | Clinical therapeutics 20091201 |
| Pharmacogenetics of antipsychotic-induced side effects. | Dialogues in clinical neuroscience 20091201 |
| Comparative Analysis of Cognitive Function in Schizophrenia with and without Obsessive Compulsive Disorder. | Psychiatry investigation 20091201 |
| Improvement of restless legs syndrome and trichotillomania with aripiprazole. | Journal of clinical pharmacy and therapeutics 20091201 |
| Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity. | European journal of pharmacology 20091125 |
| Remission of schizophrenia psychosis and strong reduction of obsessive-compulsive disorder after adding clozapine to aripiprazole. | Progress in neuro-psychopharmacology & biological psychiatry 20091113 |
| Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. | Behavioural brain research 20091105 |
| Asenapine effects in animal models of psychosis and cognitive function. | Psychopharmacology 20091101 |
| A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. | Journal of the American Academy of Child and Adolescent Psychiatry 20091101 |
| [Tics and Tourette's syndrome throughout the life span]. | Der Nervenarzt 20091101 |
| Diagnosis and treatment of comorbidities of Tourette's syndrome and bipolar disorder in a 10-year-old boy. | The Kaohsiung journal of medical sciences 20091101 |
| Packages of care for dementia in low- and middle-income countries. | PLoS medicine 20091101 |
| Effectiveness of intramuscular aripiprazole injection in patients with catatonia: report on three cases. | Pharmacopsychiatry 20091101 |
| Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine. | Journal of psychiatric practice 20091101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20091101 |
| Mixed episodes with psychotic features. | CNS spectrums 20091101 |
| Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. | JAMA 20091028 |
| Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole. | Progress in neuro-psychopharmacology & biological psychiatry 20091001 |
| Reversible Pisa syndrome associated with switching from haloperidol to aripiprazole during lithium treatment. | Progress in neuro-psychopharmacology & biological psychiatry 20091001 |
| Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder. | Psychopharmacology 20091001 |
| Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder. | Pharmacoepidemiology and drug safety 20091001 |
| Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia. | Therapeutic drug monitoring 20091001 |
| Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder. | The international journal of neuropsychopharmacology 20091001 |
| Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole. | Journal of clinical pharmacy and therapeutics 20091001 |
| Effects of aripiprazole on insight and subjective experience in individuals with an at-risk mental state. | Journal of clinical psychopharmacology 20091001 |
| Waxing-and-waning catatonia after intermittent exposure to aripiprazole in a case of autism and bipolar disorder. | Journal of clinical psychopharmacology 20091001 |
| Asymptomatic hyperamylasemia and hyperlipasemia associated with aripiprazole. | Journal of clinical psychopharmacology 20091001 |
| A case of aripiprazole-associated paroxysmal supraventricular tachycardia. | Journal of clinical psychopharmacology 20091001 |
| [Aripiprazole induced Parkinsonism: A case report]. | L'Encephale 20091001 |
| Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. | Journal of child and adolescent psychopharmacology 20091001 |
| Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality. | Journal of child and adolescent psychopharmacology 20091001 |
| Clozapine-aripiprazole association in a 7-year-old girl with schizophrenia: clinical efficacy and successful management of neutropenia with lithium. | Journal of child and adolescent psychopharmacology 20091001 |
| Aripiprazole and hypertension in adolescents. | Journal of child and adolescent psychopharmacology 20091001 |
| A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. | The Journal of clinical psychiatry 20091001 |
| Life events, medical comorbidity, and somatic symptoms in pediatric mood disorders. | The Journal of clinical psychiatry 20091001 |
| Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. | The Journal of clinical psychiatry 20091001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20091001 |
| Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. | Biological psychiatry 20090915 |
| Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice. | Psychopharmacology 20090901 |
| The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study. | Pharmacoepidemiology and drug safety 20090901 |
| Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications. | Current drug safety 20090901 |
| Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study. | International clinical psychopharmacology 20090901 |
| Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder. | CNS drugs 20090901 |
| [A new approach to antischizophrenic therapeutics: D2 dopamine receptor partial agonists]. | Annales pharmaceutiques francaises 20090901 |
| [Diabetes and second-generation (atypical) antipsychotics]. | Annales d'endocrinologie 20090901 |
| Effects of some antipsychotics and a benzodiazepine hypnotic on the sleep-wake pattern in an animal model of schizophrenia. | Journal of pharmacological sciences 20090901 |
| Therapy and quality of life of patients with psychosis. | Psychiatria Danubina 20090901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090901 |
| Psychiatric disorder in two siblings with hallervorden-spatz disease. | Psychiatry investigation 20090901 |
| The use of aripiprazole in early onset schizophrenia: safety and efficacy. | The Medical journal of Malaysia 20090901 |
| Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. | Neuroscience letters 20090821 |
| Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects. | The international journal of neuropsychopharmacology 20090801 |
| Advancing radiology through informed leadership: summary of the proceedings of the Seventh Biannual Symposium of the International Society for Strategic Studies in Radiology (IS(3)R), 23-25 August 2007. | European radiology 20090801 |
| Influence of TAAR6 polymorphisms on response to aripiprazole. | Progress in neuro-psychopharmacology & biological psychiatry 20090801 |
| HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patients. | Psychopharmacology 20090801 |
| Immediate versus gradual suspension of previous treatments during switch to aripiprazole: results of a randomized, open label study. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090801 |
| Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats. | European journal of pharmacology 20090801 |
| A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol. | Human psychopharmacology 20090801 |
| Effectiveness of second-generation antipsychotics with acute-phase schizophrenia. | Schizophrenia research 20090801 |
| Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies. | Journal of clinical psychopharmacology 20090801 |
| Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up study. | Journal of clinical psychopharmacology 20090801 |
| Potential utility of aripiprazole monotherapy for the treatment of major depressive disorder comorbid with obsessive-compulsive disorder. | Psychiatry and clinical neurosciences 20090801 |
| Using oral ziprasidone effectively: the food effect and dose-response. | Advances in therapy 20090801 |
| An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder. | Journal of child and adolescent psychopharmacology 20090801 |
| Open label aripiprazole in the treatment of youth with tic disorders. | Journal of child and adolescent psychopharmacology 20090801 |
| Focus on aripiprazole: a review of its use in child and adolescent psychiatry. | Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20090801 |
| Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials. | Journal of psychopharmacology (Oxford, England) 20090701 |
| Spatio-temporal clusters of new psychotropic medications among Michigan children insured by Medicaid. | Pharmacoepidemiology and drug safety 20090701 |
| Treatment of catatonic schizophrenia with lorazepam and aripiprazole. | Schizophrenia research 20090701 |
| A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder. | International clinical psychopharmacology 20090701 |
| Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study. | Journal of neural transmission (Vienna, Austria : 1996) 20090701 |
| Aripiprazole for the treatment of agitation in persons with dementia? | Journal of the American Medical Directors Association 20090701 |
| Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review. | Pharmacopsychiatry 20090701 |
| Aripiprazole for the management of olanzapine-induced weight gain. | Pharmacopsychiatry 20090701 |
| Risk assessment of isolated aripiprazole exposures and toxicities: a retrospective study. | Clinical toxicology (Philadelphia, Pa.) 20090701 |
| A multiattribute decision model for bipolar disorder: identification of preferred mood-stabilizing medications. | The American journal of managed care 20090701 |
| Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review. | The Journal of clinical psychiatry 20090701 |
| Aripiprazole treatment of risperidone-induced hyperprolactinemia. | The Journal of clinical psychiatry 20090701 |
| Courses of aripiprazole-associated tardive dyskinesia: report of two cases. | Progress in neuro-psychopharmacology & biological psychiatry 20090615 |
| Supersensitivity psychosis and aripiprazole tapering. | Progress in neuro-psychopharmacology & biological psychiatry 20090615 |
| Conformational polymorphism in aripiprazole: Preparation, stability and structure of five modifications. | Journal of pharmaceutical sciences 20090601 |
| Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes. | Diabetes care 20090601 |
| UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study). | European archives of psychiatry and clinical neuroscience 20090601 |
| The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics. | The international journal of neuropsychopharmacology 20090601 |
| Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs. | The Journal of clinical psychiatry 20090601 |
| Aripiprazole for the treatment of schizophrenia with co-occurring social anxiety: an open-label cross-taper study. | Journal of clinical psychopharmacology 20090601 |
| Aripiprazole augmentation for a patient with partial remission of panic disorder. | Journal of clinical psychopharmacology 20090601 |
| [Atypical antipsychotic efficacy and safety in managing delirium: a systematic review and critical analysis]. | Psychologie & neuropsychiatrie du vieillissement 20090601 |
| [Clinically relevant drug interactions with new generation antidepressants and antipsychotics]. | Therapeutische Umschau. Revue therapeutique 20090601 |
| A systematic review of cardiovascular effects after atypical antipsychotic medication overdose. | The American journal of emergency medicine 20090601 |
| Olfactory disturbance in Parkinson disease. | Archives of neurology 20090601 |
| Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. | Journal of child and adolescent psychopharmacology 20090601 |
| Aripiprazole treatment of psychosis in a child with posterior fossa retrocerebellar arachnoid cyst. | Journal of child and adolescent psychopharmacology 20090601 |
| Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. | Journal of medical economics 20090601 |
| Antipsychotic agents in the treatment of bipolar mania. | Bipolar disorders 20090601 |
| Aripiprazole: new indication. Treatment and prevention of manic episodes: just another neuroleptic. | Prescrire international 20090601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090601 |
| A liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitation of aripiprazole in human plasma. | Journal of analytical toxicology 20090601 |
| Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials. | Clinical therapeutics 20090601 |
| Anhedonia and ambivalence in schizophrenic patients with fronto-cerebellar metabolic abnormalities: a fluoro-d-glucose positron emission tomography study. | Psychiatry investigation 20090601 |
| Atypical antipsychotic drugs and the risk of sudden cardiac death. | The New England journal of medicine 20090514 |
| A UK consensus on the administration of aripiprazole for the treatment of mania. | Journal of psychopharmacology (Oxford, England) 20090501 |
| Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090501 |
| The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials. | Journal of affective disorders 20090501 |
| Aripiprazole brain concentration is altered in P-glycoprotein deficient mice. | Schizophrenia research 20090501 |
| Comparing the effectiveness of aripiprazole and quetiapine in schizophrenia and related psychoses: a naturalistic, retrospective chart review study. | The Journal of clinical psychiatry 20090501 |
| Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning. | International clinical psychopharmacology 20090501 |
| Akathisia and second-generation antipsychotic drugs. | Current opinion in psychiatry 20090501 |
| Switching to aripiprazole from olanzapine leads to weight loss in overweight people with schizophrenia or schizoaffective disorder. | Evidence-based mental health 20090501 |
| Refractory schizophrenia: adding aripiprazole to clozapine reduces negative but not overall symptoms. | Evidence-based mental health 20090501 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Bipolar disorders 20090501 |
| Update on neuropsychiatric symptoms of dementia: antipsychotic use. | Geriatrics 20090501 |
| Psychosocial functioning in patients with schizophrenia treated with aripiprazole - an office-based real-world setting. Results from the German post-marketing surveillance study. | Pharmacopsychiatry 20090501 |
| Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study. | Pharmacopsychiatry 20090501 |
| A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs. | Behavioural pharmacology 20090501 |
| Use and safety of antipsychotic drugs during pregnancy. | Journal of psychiatric practice 20090501 |
| Treatment options for the patient who does not respond well to initial antidepressant therapy. | Journal of psychiatric practice 20090501 |
| Aripiprazole in treatment-refractory schizophrenia. | Journal of psychiatric practice 20090501 |
| A review of the safety and tolerability of aripiprazole. | Expert opinion on drug safety 20090501 |
| Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need. | The Journal of clinical psychiatry 20090501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090501 |
| Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors. | Progress in neuro-psychopharmacology & biological psychiatry 20090430 |
| Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy. | Progress in neuro-psychopharmacology & biological psychiatry 20090430 |
| Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial. | The Journal of clinical psychiatry 20090421 |
| Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism. | Psychopharmacology 20090401 |
| Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers. | Drug and alcohol dependence 20090401 |
| Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole. | Therapeutic drug monitoring 20090401 |
| Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors. | European journal of pharmacology 20090401 |
| Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. | Journal of clinical pharmacy and therapeutics 20090401 |
| How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. | European psychiatry : the journal of the Association of European Psychiatrists 20090401 |
| A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia. | The Journal of clinical psychiatry 20090401 |
| [Aripiprazole and priapism]. | Atencion primaria 20090401 |
| Aripiprazole blocks reinstatement but not expression of morphine conditioned place preference in rats. | Pharmacology, biochemistry, and behavior 20090401 |
| A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia. | The Journal of clinical psychiatry 20090401 |
| Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. | Journal of personality disorders 20090401 |
| Treatment of delusional parasitosis with aripiprazole. | Archives of dermatology 20090401 |
| Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. | CNS spectrums 20090401 |
| Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis. | Clinical therapeutics 20090401 |
| Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. | Journal of clinical psychopharmacology 20090401 |
| Tardive dyskinesia due to aripiprazole: report of 2 cases. | Journal of clinical psychopharmacology 20090401 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090401 |
| Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy. | Journal of proteome research 20090401 |
| Aripiprazole-induced sialorrhea. | Progress in neuro-psychopharmacology & biological psychiatry 20090317 |
| Supersensitivity psychosis after tapering aripiprazole: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20090317 |
| A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia. | Biological psychiatry 20090315 |
| Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour. | Journal of psychopharmacology (Oxford, England) 20090301 |
| Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone. | Journal of psychopharmacology (Oxford, England) 20090301 |
| A case of aripiprazole and tardive dyskinesia. | Journal of psychopharmacology (Oxford, England) 20090301 |
| Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients. | Journal of psychiatric research 20090301 |
| Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder. | Schizophrenia research 20090301 |
| A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder. | Human psychopharmacology 20090301 |
| The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia. | The Journal of clinical psychiatry 20090301 |
| Evaluation of Peakmaster for computer-aided multivariate optimisation of a CE separation of 17 antipsychotic drugs using minimal experimental data. | Electrophoresis 20090301 |
| Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients. | Journal of psychiatric practice 20090301 |
| Multiple sclerosis presenting with erotomanic delusions in the context of 'Don't ask, don't tell'. | Military medicine 20090301 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090301 |
| Review of the efficacy of placebo in comparative clinical trials between typical and atypical antipsychotics. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20090301 |
| Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approaches. | Psychiatry investigation 20090301 |
| Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20090218 |
| Development of an LC-MS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human plasma. | Analytical biochemistry 20090215 |
| Refractory restless legs syndrome likely caused by olanzapine. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215 |
| Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission. | The Journal of clinical psychiatry 20090210 |
| Severe hyperglycemic hyperosmolar nonketotic coma in a nondiabetic patient receiving aripiprazole. | Annals of emergency medicine 20090201 |
| Do patients with schizophrenia exhibit aberrant salience? | Psychological medicine 20090201 |
| A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic. | Community mental health journal 20090201 |
| Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report. | Progress in neuro-psychopharmacology & biological psychiatry 20090201 |
| Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. | Human molecular genetics 20090201 |
| A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. | The American journal of psychiatry 20090201 |
| Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. | Schizophrenia research 20090201 |
| Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients. | Journal of clinical psychopharmacology 20090201 |
| An open study of aripiprazole and escitalopram for psychotic major depressive disorder. | Journal of clinical psychopharmacology 20090201 |
| Aripiprazole in refractory depression? | Journal of clinical psychopharmacology 20090201 |
| Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al. | Journal of clinical psychopharmacology 20090201 |
| Successful switch from clozapine to aripiprazole: a case report. | Journal of clinical psychopharmacology 20090201 |
| Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study. | Psychiatry and clinical neurosciences 20090201 |
| Aripiprazole for psychosis and agitation in Alzheimer's dementia. | Current psychiatry reports 20090201 |
| Metabolic risks in older adults receiving second-generation antipsychotic medication. | Current psychiatry reports 20090201 |
| Psychosis in the elderly. | The American journal of psychiatry 20090201 |
| Prolonged toxicity in a 2-year-old after accidental ingestion of aripiprazole. | Pediatric emergency care 20090201 |
| Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol. | CNS spectrums 20090201 |
| [A new pharmacological strategy for schizophrenia: the partial agonists of D2 dopaminergic receptors. The principle characteristics of aripiprazole]. | L'Encephale 20090201 |
| Benign clinical picture after ingestion of 780 milligrams of aripiprazole and 1050 milligrams of amitriptyline. | Indian journal of medical sciences 20090201 |
| Transport of aripiprazole across Caco-2 monolayer model. | Yao xue xue bao = Acta pharmaceutica Sinica 20090201 |
| Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients. | Psychiatry research 20090130 |
| Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine. | Movement disorders : official journal of the Movement Disorder Society 20090115 |
| Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior. | Journal of medicinal chemistry 20090108 |
| Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. | Lancet (London, England) 20090103 |
| Combined use of ECT with aripiprazole. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| Combined low-dose clozapine with low-dose aripiprazole in a schizophrenic patient. | Journal of psychopharmacology (Oxford, England) 20090101 |
| Leukopenia and thrombocytopenia on adding aripiprazole to phenytoin. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors. | Psychopharmacology 20090101 |
| A placebo-controlled study of sildenafil effects on cognition in schizophrenia. | Psychopharmacology 20090101 |
| Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. | Journal of affective disorders 20090101 |
| Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| Results of phase 3 of the CATIE schizophrenia trial. | Schizophrenia research 20090101 |
| Treatment of alternating hemiplegia of childhood with aripiprazole. | Developmental medicine and child neurology 20090101 |
| A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia. | Journal of the American Medical Directors Association 20090101 |
| Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. | The British journal of psychiatry : the journal of mental science 20090101 |
| Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics. | The American journal of psychiatry 20090101 |
| Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? | Current drug safety 20090101 |
| The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies. | The Journal of clinical psychiatry 20090101 |
| Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis. | Psychopharmacology bulletin 20090101 |
| An open-label assessment of aripiprazole in the treatment of PTSD. | Psychopharmacology bulletin 20090101 |
| Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study. | Annals of general psychiatry 20090101 |
| Aripiprazole-induced agitation after clozapine discontinuation: a case report. | The Journal of clinical psychiatry 20090101 |
| A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF). | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. | Nutrition & metabolism 20090101 |
| Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study. | Child and adolescent psychiatry and mental health 20090101 |
| Central sleep apnea in a geriatric patient treated with aripiprazole. | American journal of therapeutics 20090101 |
| Haloperidol changes mRNA expression of a QKI splice variant in human astrocytoma cells. | BMC pharmacology 20090101 |
| Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials. | BMC psychiatry 20090101 |
| No relationship between 2',3'-cyclic nucleotide 3'-phosphodiesterase and schizophrenia in the Chinese Han population: an expression study and meta-analysis. | BMC medical genetics 20090101 |
| Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States. | Cost effectiveness and resource allocation : C/E 20090101 |
| Antipsychotic and antiepileptic drugs in bipolar disorder: the importance of therapeutic drug monitoring. | Current medicinal chemistry 20090101 |
| Sertindole versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20090101 |
| [Paroxysmal perceptual alteration in comparison with hallucination--a review of its clinical reports and discussion of its pathophysiological mechanism in the present day, when second generation antipsychotics are widely used]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20090101 |
| [Severe and acute hyponatremia in a schizophrenic patient with potomania]. | Anales del sistema sanitario de Navarra 20090101 |
| Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia. | Trials 20090101 |
| Schizophrenia pathophysiology: are we any closer to a complete model? | Annals of general psychiatry 20090101 |
| Utility of atypical antipsychotics in the treatment of resistant unipolar depression. | CNS drugs 20090101 |
| Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. | CNS drugs 20090101 |
| Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. | CNS drugs 20090101 |
| Efficacy and tolerability of aripiprazole in first-episode drug-naive patients with schizophrenia: an open-label trial. | Clinical neuropharmacology 20090101 |
| Use of aripiprazole in tardive dyskinesia: an open label study of six cases. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| Aripiprazole-induced hiccups: a case report. | General hospital psychiatry 20090101 |
| Aripiprazole in the treatment of Huntington's disease: a case series. | Neuropsychiatric disease and treatment 20090101 |
| A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole. | Neuropsychiatric disease and treatment 20090101 |
| Psychopharmacology of ADHD in pediatrics: current advances and issues. | Neuropsychiatric disease and treatment 20090101 |
| Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole. | Neuropsychiatric disease and treatment 20090101 |
| Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults. | BMC medical imaging 20090101 |
| Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues. | Neuropsychiatric disease and treatment 20090101 |
| Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia. | Clinical neuropharmacology 20090101 |
| Chronic motor tic disorder and aripiprazole. | The Journal of neuropsychiatry and clinical neurosciences 20090101 |
| Formulation optimization of long-acting depot injection of aripiprazole by using D-optimal mixture design. | PDA journal of pharmaceutical science and technology 20090101 |
| Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review. | Annals of general psychiatry 20090101 |
| Why do delusions persist? | Frontiers in human neuroscience 20090101 |
| The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia. | Clinical neuropharmacology 20090101 |
| Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole. | Clinical neuropharmacology 20090101 |
| Switching of antipsychotics to aripiprazole in the treatment of schizophrenia. | Chang Gung medical journal 20090101 |
| Tardive dyskinesia in a patient treated with quetiapine. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorogenic hyperprolactinemia. | Psychosomatics 20090101 |
| Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials. | General hospital psychiatry 20090101 |
| Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials. | Applied health economics and health policy 20090101 |
| Teratogenicity and hyperprolactinemia. | Indian journal of psychiatry 20090101 |
| Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia. | Clinical interventions in aging 20090101 |
| A systematic review of augmentation strategies for patients with major depressive disorder. | Psychopharmacology bulletin 20090101 |
| Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects. | BMC psychiatry 20090101 |
| Improvement in Pisa syndrome and tardive dyskinesia following aripiprazole treatment. | The Journal of neuropsychiatry and clinical neurosciences 20090101 |
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090101 |
| [Aripiprazole and acute dystonia]. | Tijdschrift voor psychiatrie 20090101 |
| Aripiprazole versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20090101 |
| Ziprasidone versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20090101 |
| Memantine in the management of a clinically challenging case of bipolar disorder. | Indian journal of psychiatry 20090101 |
| Treatment with aripiprazole and topiramate in an obese subject with borderline personality disorder, obsessive-compulsive symptoms and bulimia nervosa: a case report. | Cases journal 20090101 |
| Development of Parkinsonism following exposure to aripiprazole: two case reports. | Journal of medical case reports 20090101 |
| Schizophrenia-like psychosis following left putamen infarct: a case report. | Journal of medical case reports 20090101 |
| Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder. | Neuropsychiatric disease and treatment 20090101 |
| Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia. | Neuropsychiatric disease and treatment 20090101 |
| Movement disorders associated with aripiprazole use: a case series. | The International journal of neuroscience 20090101 |
| Rotarod impairment: catalepsy-like screening test for antipsychotic side effects. | The International journal of neuroscience 20090101 |
| Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. | The Journal of clinical psychiatry 20090101 |
| Algorithms for the assessment and management of insomnia in primary care. | Patient preference and adherence 20090101 |
| Treating bipolar disorder in the primary care setting: the role of aripiprazole. | Primary care companion to the Journal of clinical psychiatry 20090101 |
| Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice. | PloS one 20090101 |
| Motor function may differentiate attention deficit hyperactivity disorder from early onset bipolar disorder. | Behavioral and brain functions : BBF 20090101 |
| Fall-related injuries in a nursing home setting: is polypharmacy a risk factor? | BMC health services research 20090101 |
| Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection. | Patient preference and adherence 20090101 |
| Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis. | Annals of general psychiatry 20090101 |
| Current perspectives in the treatment of resistant schizophrenia. | Indian journal of psychiatry 20090101 |
| Severe anorexia nervosa, co-occurring major depressive disorder and electroconvulsive therapy as maintenance treatment: a case report. | Cases journal 20090101 |
| Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163). | Primary care companion to the Journal of clinical psychiatry 20090101 |
| [Pharmacotherapy in the treatment of borderline personality disorder]. | Rivista di psichiatria 20090101 |
| Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients. | Indian journal of pharmaceutical sciences 20090101 |
| Catatonia and CPK elevation in neurosyphilis: role of plural pharmacodynamic mechanisms. | Psychopharmacology bulletin 20090101 |
| Behavioral and psychological symptoms of dementia and their management. | Indian journal of psychiatry 20090101 |
| Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia. | Indian journal of psychiatry 20090101 |
| Motor worsening and tardive dyskinesia with aripiprazole in Lewy body dementia. | BMJ case reports 20090101 |
| Antipsychotic-induced urinary dysfunction: anticholinergic effect or otherwise? | BMJ case reports 20090101 |
| Aripiprazole-induced seizure: a second case report. | BMJ case reports 20090101 |
| Olanzapine induced tardive dystonia in case of adolescent bipolar disorder. | Journal of pediatric neurosciences 20090101 |
| Cannabis and schizophrenia spectrum disorders: a review of clinical studies. | Indian journal of psychological medicine 20090101 |
| Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? | Behavioural brain research 20081216 |
| Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer. | European journal of pharmacology 20081214 |
| Aripiprazole treatment for depression in schizoaffective disorder. | Progress in neuro-psychopharmacology & biological psychiatry 20081212 |
| Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole. | Progress in neuro-psychopharmacology & biological psychiatry 20081212 |
| Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care. | European psychiatry : the journal of the Association of European Psychiatrists 20081201 |
| Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081201 |
| Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. | The international journal of neuropsychopharmacology 20081201 |
| Neurological adverse events associated with antipsychotic treatment in children and adolescents. | Journal of child neurology 20081201 |
| Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20081201 |
| Dopamine D2(High) receptors moderately elevated by bifeprunox and aripiprazole. | Synapse (New York, N.Y.) 20081201 |
| [Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics]. | Fortschritte der Neurologie-Psychiatrie 20081201 |
| One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia. | Current medical research and opinion 20081201 |
| Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine. | Schizophrenia research 20081201 |
| Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. | Journal of clinical psychopharmacology 20081201 |
| Antidepressant-induced sweating alleviated by aripiprazole. | Journal of clinical psychopharmacology 20081201 |
| Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients. | The Journal of clinical psychiatry 20081201 |
| Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients. | British journal of clinical pharmacology 20081201 |
| Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial. | Expert opinion on pharmacotherapy 20081201 |
| Market watch : Pharma industry strategic performance: 2007-2012E. | Nature reviews. Drug discovery 20081201 |
| An olfactory reference syndrome successfully treated by aripiprazole augmentation of antidepressant therapy. | Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 20081201 |
| Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify). | Experimental and clinical psychopharmacology 20081201 |
| Aripiprazole in the treatment of posttraumatic stress disorder: an open-label trial. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20081201 |
| Incomplete response in late-life depression: getting to remission. | Dialogues in clinical neuroscience 20081201 |
| Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features. | The Journal of clinical psychiatry 20081201 |
| A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation. | The Journal of clinical psychiatry 20081201 |
| Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature. | Neuropsychiatric disease and treatment 20081201 |
| Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder. | Psychiatry research 20081130 |
| Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds. | European journal of pharmacology 20081112 |
| Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors. | European journal of pharmacology 20081112 |
| Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review. | Schizophrenia bulletin 20081101 |
| Use of Aripiprazole in treatment resistant schizophrenia. | Journal of psychopharmacology (Oxford, England) 20081101 |
| Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats. | Psychopharmacology 20081101 |
| Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study. | Diabetes & metabolism 20081101 |
| Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: possible relevance to neuroprotective interventions in schizophrenia. | Synapse (New York, N.Y.) 20081101 |
| Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. | The international journal of neuropsychopharmacology 20081101 |
| A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. | The American journal of psychiatry 20081101 |
| Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control. | Alcoholism, clinical and experimental research 20081101 |
| Short-term physical compatibility of intramuscular aripiprazole with intramuscular lorazepam. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081101 |
| Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK . | Current medical research and opinion 20081101 |
| Adjunctive aripiprazole improves symptoms in antidepressant refractory major depressive disorder. | Evidence-based mental health 20081101 |
| Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine. | The American journal of psychiatry 20081101 |
| Potentiation of the antidepressant-like effect of fluoxetine by aripiprazole in the mouse tail suspension test. | Journal of pharmacological sciences 20081101 |
| Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome. | Journal of psychiatric practice 20081101 |
| Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. | The American journal of psychiatry 20081001 |
| Amphetamine as a risk factor for aripiprazole-induced acute dystonia. | Progress in neuro-psychopharmacology & biological psychiatry 20081001 |
| Catatonia resolution and aripiprazole. | The Australian and New Zealand journal of psychiatry 20081001 |
| The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials. | Schizophrenia research 20081001 |
| A clinical paradigm of delusions of parasitosis. | Journal of the American Academy of Dermatology 20081001 |
| A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering. | Journal of clinical psychopharmacology 20081001 |
| Aripiprazole induced hypersexuality in a 24-year-old female patient with schizoaffective disorder? | Journal of clinical psychopharmacology 20081001 |
| An open-label study of aripiprazole in nonschizophrenic crack-dependent patients. | Journal of clinical psychopharmacology 20081001 |
| Bipolar drug development: are we getting closer to the real world? | The American journal of psychiatry 20081001 |
| Changing trends in pediatric antipsychotic use in Florida's Medicaid program. | Psychiatric services (Washington, D.C.) 20081001 |
| Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. | Psychiatric services (Washington, D.C.) 20081001 |
| Current evidence for aripiprazole as augmentation therapy in major depressive disorder. | Expert review of neurotherapeutics 20081001 |
| Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. | Journal of child and adolescent psychopharmacology 20081001 |
| Psychosis or atypical neuroleptic malignant syndrome in an adolescent? | Journal of child and adolescent psychopharmacology 20081001 |
| Unusual weight fluctuation under corticosteroid and psychotropic treatment. | Psychiatry and clinical neurosciences 20081001 |
| Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia. | Psychiatry and clinical neurosciences 20081001 |
| Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. | The American journal of geriatric pharmacotherapy 20081001 |
| Augmentation treatment in major depressive disorder: focus on aripiprazole. | Neuropsychiatric disease and treatment 20081001 |
| An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. | Neuropsychiatric disease and treatment 20081001 |
| The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. | European journal of pharmacology 20080911 |
| Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms. | European journal of pharmacology 20080911 |
| [The neuroleptic treatment of delusional parasitosis: first experiences with aripiprazole]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20080901 |
| The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain. | The international journal of neuropsychopharmacology 20080901 |
| A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression. | Journal of affective disorders 20080901 |
| Who responds to aripiprazole in clinical practice? An observational study of combination versus monotherapy. | Journal of psychopharmacology (Oxford, England) 20080901 |
| Delusional disorder, somatic type treated with aripiprazole--mirtazapine combination. | Journal of psychopharmacology (Oxford, England) 20080901 |
| The safety of the electroconvulsive therapy-aripiprazole combination: four case reports. | The journal of ECT 20080901 |
| Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole. | The Annals of pharmacotherapy 20080901 |
| Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. | Behavioural pharmacology 20080901 |
| Combination of aripiprazole and other psychopharmacological treatments in resistant and multi-resistant patients. | Current drug safety 20080901 |
| A 12-month follow-up study of treating overweight schizophrenic patients with aripiprazole. | Acta psychiatrica Scandinavica 20080901 |
| Practical guidance for prescribing with aripiprazole in bipolar disorder. | Current medical research and opinion 20080901 |
| Diabetic ketoacidosis associated with aripiprazole. | Pharmacotherapy 20080901 |
| Aripiprazole in the treatment of primary delusional parasitosis. | The British journal of psychiatry : the journal of mental science 20080901 |
| Aripiprazole effects on psychosis and chorea in a patient with Huntington's disease. | The American journal of psychiatry 20080901 |
| Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting. | Psychiatria Danubina 20080901 |
| [The use of antipsychotics in patients with dementia]. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20080901 |
| Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole. | Clinical interventions in aging 20080901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20080901 |
| Predictors of aripiprazole treatment continuation in hospitalized patients. | The Journal of clinical psychiatry 20080901 |
| Dextromethorphan-induced serotonin syndrome. | Clinical toxicology (Philadelphia, Pa.) 20080901 |
| Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors. | Behavioural brain research 20080805 |
| Aripiprazole-induced rabbit syndrome in a drug-naive schizophrenic patient. | Schizophrenia research 20080801 |
| Controversies in translational research: drug self-administration. | Psychopharmacology 20080801 |
| Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study. | The American journal of psychiatry 20080801 |
| Combined antipsychotic treatment involving clozapine and aripiprazole. | Progress in neuro-psychopharmacology & biological psychiatry 20080801 |
| Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: results from the STAR study. | European psychiatry : the journal of the Association of European Psychiatrists 20080801 |
| Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. | Human molecular genetics 20080801 |
| Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study. | Journal of clinical psychopharmacology 20080801 |
| Aripiprazole in a case presenting with tourette syndrome and obsessive-compulsive disorder. | Journal of clinical psychopharmacology 20080801 |
| Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series. | Journal of clinical psychopharmacology 20080801 |
| Case report of aripiprazole for persistent developmental stuttering. | Journal of clinical psychopharmacology 20080801 |
| Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia. | Therapeutic drug monitoring 20080801 |
| New insights into clinical response in schizophrenia: from dopamine D2 receptor occupancy to patients' quality of life. | The American journal of psychiatry 20080801 |
| Aripiprazole in children with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20080801 |
| Adjunctive aripiprazole decreased metabolic side effects of clozapine treatment. | Neuro endocrinology letters 20080801 |
| Aripiprazole-induced orthostatic hypotension and cardiac arrhythmia. | Psychiatry and clinical neurosciences 20080801 |
| Current approaches to the treatment of Parkinson's disease. | Neuropsychiatric disease and treatment 20080801 |
| Aripiprazole versus typical antipsychotic drugs for schizophrenia. | The Cochrane database of systematic reviews 20080716 |
| Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s. | European journal of pharmacology 20080707 |
| Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature. | Progress in neuro-psychopharmacology & biological psychiatry 20080701 |
| Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats. | Journal of psychopharmacology (Oxford, England) 20080701 |
| The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients. | Basic & clinical pharmacology & toxicology 20080701 |
| Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro. | Journal of neurochemistry 20080701 |
| Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms. | Progress in neuro-psychopharmacology & biological psychiatry 20080701 |
| Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. | Psychopharmacology 20080701 |
| Adjunctive aripiprazole for bupropion-resistant major depression. | The Annals of pharmacotherapy 20080701 |
| Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. | Acta psychiatrica Scandinavica 20080701 |
| Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function. | Psychopharmacology 20080701 |
| Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. | The Journal of clinical psychiatry 20080701 |
| Case report of aripiprazole usage during pregnancy. | Archives of women's mental health 20080701 |
| A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20080701 |
| Significance of findings in aripiprazole for treatment of psychoses in Alzheimer dementia. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20080701 |
| A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine. | The Journal of clinical psychiatry 20080701 |
| D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole. | Drug development and industrial pharmacy 20080701 |
| Aripiprazole reduces serum prolactin in a woman with prolactinoma and acute psychosis. | Pharmacopsychiatry 20080701 |
| Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug. | Drug metabolism and disposition: the biological fate of chemicals 20080601 |
| Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization. | Journal of neural transmission (Vienna, Austria : 1996) 20080601 |
| Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression. | Psychoneuroendocrinology 20080601 |
| Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling. | Neuropharmacology 20080601 |
| Antipsychotic drug action: antagonism, inverse agonism or partial agonism. | Trends in pharmacological sciences 20080601 |
| Proposed strategies for successful clinical management with aripiprazole. | Expert opinion on pharmacotherapy 20080601 |
| Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study. | Journal of clinical psychopharmacology 20080601 |
| Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms. | Journal of clinical psychopharmacology 20080601 |
| Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report. | Journal of clinical psychopharmacology 20080601 |
| Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats. | Metabolic brain disease 20080601 |
| Diabetic ketoacidosis induced by aripiprazole in a 12-year-old boy. | Diabetes care 20080601 |
| First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. | The British journal of psychiatry : the journal of mental science 20080601 |
| Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. | Current drug metabolism 20080601 |
| Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. | CNS spectrums 20080601 |
| Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. | CNS spectrums 20080601 |
| Successful treatment of delusional disorder with low-dose aripiprazole. | Psychiatry and clinical neurosciences 20080601 |
| [Evaluation of antipsychotic and relative drugs using disruption of prepulse inhibition as an animal model for schizophrenia]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20080601 |
| Apparent commercial bias in supplement. | The Journal of clinical psychiatry 20080601 |
| Is aripiprazole an efficacious adjunct for unipolar depression? | The Journal of clinical psychiatry 20080601 |
| Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. | Clinical interventions in aging 20080601 |
| Acute and long-term treatment of mania. | Dialogues in clinical neuroscience 20080601 |
| Bipolar depression: trial-based insights to guide patient care. | Dialogues in clinical neuroscience 20080601 |
| Current research in child and adolescent bipolar disorder. | Dialogues in clinical neuroscience 20080601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20080601 |
| Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial. | Neuropsychiatric disease and treatment 20080601 |
| Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD). | Current neuropharmacology 20080601 |
| Cognitive factors for predicting treatment response in schizophrenic patients: one-year follow-up study. | Psychiatry investigation 20080601 |
| Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080501 |
| Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells. | The international journal of neuropsychopharmacology 20080501 |
| New treatments for cocaine dependence: a focused review. | The international journal of neuropsychopharmacology 20080501 |
| Dysfunction in configural face processing in patients with schizophrenia. | Schizophrenia bulletin 20080501 |
| Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome. | The international journal of neuropsychopharmacology 20080501 |
| Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report. | Journal of psychopharmacology (Oxford, England) 20080501 |
| Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder. | Psychopharmacology 20080501 |
| Change in sexual dysfunction with aripiprazole: a switching or add-on study. | Journal of psychopharmacology (Oxford, England) 20080501 |
| Prolactin awareness: an essential consideration for physical health in schizophrenia. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080501 |
| Development and validation of a high-performance liquid chromatography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080501 |
| Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial. | The Journal of clinical psychiatry 20080501 |
| Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study. | International journal of clinical practice 20080501 |
| Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care. | The Journal of clinical psychiatry 20080501 |
| Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements. | Psychiatric services (Washington, D.C.) 20080501 |
| Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006. | Psychiatric services (Washington, D.C.) 20080501 |
| Aripiprazole joins the family of second-generation mood stabilizers. | The Journal of clinical psychiatry 20080501 |
| Intrinsic activity of aripiprazole is not 30% of dopamine, but only about 6% under ideal antipsychotic therapy. | The Journal of clinical psychiatry 20080501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20080501 |
| Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder. | Psychiatry (Edgmont (Pa. : Township)) 20080501 |
| Analysis of the recent antipsychotic aripiprazole in human plasma by capillary electrophoresis and high-performance liquid chromatography with diode array detection. | Analytica chimica acta 20080407 |
| Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. | Journal of affective disorders 20080401 |
| Aripiprazole resolves symptomatic hyperprolactinemia in a male schizophrenic patient. | Progress in neuro-psychopharmacology & biological psychiatry 20080401 |
| [Current pharmacotherapies and immunotherapy in cocaine addiction]. | Presse medicale (Paris, France : 1983) 20080401 |
| Aripiprazole as an adjunctive treatment for refractory unipolar depression. | Progress in neuro-psychopharmacology & biological psychiatry 20080401 |
| Aripiprazole treatment for risperidone-associated tic movement: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20080401 |
| Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. | Acta psychiatrica Scandinavica 20080401 |
| Effects of aripiprazole on subjective and physiological responses to alcohol. | Alcoholism, clinical and experimental research 20080401 |
| Partial agonists and suicide: the role of the mental health nurse. | Journal of psychiatric and mental health nursing 20080401 |
| Sexual dysfunction in schizophrenia: focus on recent evidence. | Human psychopharmacology 20080401 |
| The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. | Journal of clinical psychopharmacology 20080401 |
| Photo-onycholysis caused by olanzapine and aripiprazole. | Journal of clinical psychopharmacology 20080401 |
| Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials. | Journal of clinical psychopharmacology 20080401 |
| Acute dystonic reaction after initiating aripiprazole monotherapy in a 20-year-old man. | Journal of clinical psychopharmacology 20080401 |
| Delayed presentation of an aripiprazole overdose. | Clinical toxicology (Philadelphia, Pa.) 20080401 |
| Effect of aripiprazole on 5-HT2 receptor-mediated wet-dog shake responses and disruption of prepulse inhibition in rats. | Journal of pharmacological sciences 20080401 |
| Do dopamine partial agonists have partial efficacy as antipsychotics? | CNS spectrums 20080401 |
| Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder. | Journal of child and adolescent psychopharmacology 20080401 |
| The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: a cross-sectional exploratory study. | Clinical therapeutics 20080401 |
| [Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature]. | L'Encephale 20080401 |
| [Atypical antipsychotics in first-episode psychosis: a review]. | L'Encephale 20080401 |
| Effect of 17beta-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats. | Neuropsychiatric disease and treatment 20080401 |
| Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex. | The international journal of neuropsychopharmacology 20080301 |
| [Recurrent dysregulation of body temperature during antipsychotic pharmacotherapy]. | Psychiatrische Praxis 20080301 |
| Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004. | Current medical research and opinion 20080301 |
| Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects. | The American journal of psychiatry 20080301 |
| Aripiprazole's receptor pharmacology and extrapyramidal side effects. | The American journal of psychiatry 20080301 |
| Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice. | Behavioural pharmacology 20080301 |
| Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder. | The Journal of clinical psychiatry 20080301 |
| The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice. | Alcohol (Fayetteville, N.Y.) 20080301 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20080301 |
| Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells. | European journal of pharmacology 20080226 |
| Effectiveness of aripiprazole in treating obsessive compulsive symptoms. | Progress in neuro-psychopharmacology & biological psychiatry 20080215 |
| Tardive dystonic symptoms associated with aripiprazole treatment. | Progress in neuro-psychopharmacology & biological psychiatry 20080215 |
| Aripiprazole: a treatment for severe coprolalia in 'refractory' Gilles de la Tourette syndrome. | Movement disorders : official journal of the Movement Disorder Society 20080215 |
| Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain. | Journal of neuroscience research 20080201 |
| Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats. | Neuropharmacology 20080201 |
| Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers. | Pharmacogenetics and genomics 20080201 |
| A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. | Journal of clinical psychopharmacology 20080201 |
| Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. | Journal of clinical psychopharmacology 20080201 |
| A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. | The Journal of clinical psychiatry 20080201 |
| Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone. | Evidence-based mental health 20080201 |
| Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. | European journal of clinical pharmacology 20080201 |
| Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol. | The Journal of clinical psychiatry 20080201 |
| Quetiapine monotherapy for bipolar depression. | Neuropsychiatric disease and treatment 20080201 |
| Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder. | Neuropsychiatric disease and treatment 20080201 |
| Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia. | Neuropsychiatric disease and treatment 20080201 |
| Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats. | Behavioural brain research 20080125 |
| Aripiprazole versus typicals for schizophrenia. | The Cochrane database of systematic reviews 20080123 |
| Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice. | European journal of pharmacology 20080114 |
| [Aripiprazole for the treatment of Tourette's syndrome]. | Ugeskrift for laeger 20080107 |
| Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. | Depression and anxiety 20080101 |
| Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. | Schizophrenia research 20080101 |
| Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. | Molecular psychiatry 20080101 |
| Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20080101 |
| Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. | Schizophrenia bulletin 20080101 |
| Reversal of trichotillomania with aripiprazole. | Depression and anxiety 20080101 |
| Effects of aripiprazole and terguride on dopamine synthesis in the dorsal striatum and medial prefrontal cortex of preweanling rats. | Journal of neural transmission (Vienna, Austria : 1996) 20080101 |
| The effect of aripiprazole on prepulse inhibition of the startle response in normal and hyperdopaminergic states in rats. | The International journal of neuroscience 20080101 |
| Buspirone for autistic disorder in a woman with an intellectual disability. | The Annals of pharmacotherapy 20080101 |
| Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo. | Nuclear medicine and biology 20080101 |
| Aripiprazole is associated with early onset of Tardive Dyskinesia like presentation in a patient with ABI and psychosis. | Brain injury 20080101 |
| Electroconvulsive therapy in the treatment of mixed states in bipolar disorder. | European psychiatry : the journal of the Association of European Psychiatrists 20080101 |
| Olfactory reference syndrome. | Psychosomatics 20080101 |
| Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. | Journal of psychiatric practice 20080101 |
| Antipsychotic drugs alter neuronal development including ALM neuroblast migration and PLM axonal outgrowth in Caenorhabditis elegans. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20080101 |
| Recognizing thyrotoxicosis in a patient with bipolar mania: a case report. | Annals of general psychiatry 20080101 |
| Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004). | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101 |
| Aripiprazole diminishes cannabis use in schizophrenia. | The Journal of neuropsychiatry and clinical neurosciences 20080101 |
| Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. | The Journal of clinical psychiatry 20080101 |
| Incorporating clinical guidelines through clinician decision-making. | Implementation science : IS 20080101 |
| Intramuscular aripiprazole : a review of its use in the management of agitation in schizophrenia and bipolar I disorder. | CNS drugs 20080101 |
| The use of atypical antipsychotics after traumatic brain injury. | The Journal of head trauma rehabilitation 20080101 |
| Antipsychotic-induced oxidative stress in rat brain. | Neurotoxicity research 20080101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20080101 |
| Cost of antipsychotic polypharmacy in the treatment of schizophrenia. | BMC psychiatry 20080101 |
| Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence. | CNS drugs 20080101 |
| Effectiveness of second generation antipsychotics: a systematic review of randomized trials. | BMC psychiatry 20080101 |
| Clozapine and co-prescribed psychotropics: a short report. | Clinical practice and epidemiology in mental health : CP & EMH 20080101 |
| Aripiprazole in prodromal psychosis: a case report. | Primary care companion to the Journal of clinical psychiatry 20080101 |
| Incentive motivation in first-episode psychosis: a behavioural study. | BMC psychiatry 20080101 |
| [Advances in the treatment of mania: aripiprazole]. | Actas espanolas de psiquiatria 20080101 |
| Diabetic control and atypical antipsychotics: a case report. | Journal of medical case reports 20080101 |
| Pharmacological management of atypical antipsychotic-induced weight gain. | CNS drugs 20080101 |
| Aripiprazole in adolescents with schizophrenia: profile report. | CNS drugs 20080101 |
| [Present data and treatment schedule of aripiprazole in the treatment of schizophrenia]. | L'Encephale 20080101 |
| Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient. | Clinical neuropharmacology 20080101 |
| The use of atypical antipsychotics in pediatric bipolar disorder. | The Journal of clinical psychiatry 20080101 |
| Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. | The Journal of clinical psychiatry 20080101 |
| Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. | The Journal of clinical psychiatry 20080101 |
| Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders. | The Journal of clinical psychiatry 20080101 |
| Decrease in tobacco consumption after treatment with topiramate and aripiprazole: a case report. | Journal of medical case reports 20080101 |
| [Reaction to 'Augmentation with atypical antipsychotics in the treatment of patients with a therapy-resistant depression: a review']. | Tijdschrift voor psychiatrie 20080101 |
| Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia. | Clinical pharmacokinetics 20080101 |
| Worsening of psychosis in a 30 year old man with undifferentiated schizophrenia. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101 |
| Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation. | Parkinsonism & related disorders 20080101 |
| Commentary on strategies for switching antipsychotics. | BMC medicine 20080101 |
| Neurobiology confirms psychopathology. On the antagonism of psychosis and obsessive-compulsive syndromes. | Psychopathology 20080101 |
| Delirium and its treatment. | CNS drugs 20080101 |
| Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole. | Clinical pharmacokinetics 20080101 |
| Small doses of aripiprazole augmentation of antidepressant treatment: a report of 3 cases. | Primary care companion to the Journal of clinical psychiatry 20080101 |
| Pathophysiology and treatment of psychosis in Parkinson's disease: a review. | Drugs & aging 20080101 |
| Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010). | Psychopharmacology bulletin 20080101 |
| [Brain in the core of metabolic regulations: disorders in schizophrenic patients treated with atypical antipsychotics]. | Revue medicale de Liege 20080101 |
| [Emergent mania with atypical antipsychotics: review of the literature about one case]. | Therapie 20080101 |
| The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation. | Child and adolescent psychiatry and mental health 20080101 |
| Costs of treating patients with schizophrenia who have illness-related crisis events. | BMC psychiatry 20080101 |
| Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. | Annals of general psychiatry 20080101 |
| Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. | Progress in brain research 20080101 |
| Aripiprazole-induced acneiform eruption. | General hospital psychiatry 20080101 |
| Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use. | PloS one 20080101 |
| Coverage of atypical antipsychotics among medicare drug plans in the state of washington for fiscal year 2007. | Primary care companion to the Journal of clinical psychiatry 20080101 |
| Aripiprazole: in major depressive disorder. | CNS drugs 20080101 |
| Antipsychotic-induced hyponatremia: case report and literature review. | American journal of therapeutics 20080101 |
| Clinical trials with a new atypical antipsychotic (Aripiprazole): gender specific information analysis. | Women & health 20080101 |
| The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period. | The American journal of drug and alcohol abuse 20080101 |
| Effective treatment of premenstrual violence in major depression: augmentation with aripiprazole. | Chang Gung medical journal 20080101 |
| Cognitive-enhancing effects of aripiprazole: a case report. | Clinical practice and epidemiology in mental health : CP & EMH 20080101 |
| Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation. | Health and quality of life outcomes 20080101 |
| Pharmacotherapy of methamphetamine addiction: an update. | Substance abuse 20080101 |
| Treatment-resistant depression: recent developments and future directions. | Depression and anxiety 20080101 |
| The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). | BMC psychiatry 20080101 |
| Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report. | Annals of general psychiatry 20080101 |
| Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder. | The Journal of clinical psychiatry 20080101 |
| Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies. | Primary care companion to the Journal of clinical psychiatry 20080101 |
| Aripiprazole in schizotypal personality disorder: a case report. | Primary care companion to the Journal of clinical psychiatry 20080101 |
| A case of pancreatitis associated with aripiprazole in the absence of hyperglycemia. | Primary care companion to the Journal of clinical psychiatry 20080101 |
| Aripiprazole (abilify) and tardive dyskinesia. | P & T : a peer-reviewed journal for formulary management 20080101 |
| Hyperprolactinaemia with amisulpride. | Indian journal of psychiatry 20080101 |
| Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia. | Patient preference and adherence 20080101 |
| A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. | Journal of psychiatric research 20071201 |
| Variables affecting prepulse inhibition of the startle reflex and the response to antipsychotics in DBA/2NCrl mice. | Psychopharmacology 20071201 |
| Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole. | European journal of clinical pharmacology 20071201 |
| A prospective 6-month analysis of the naturalistic use of aripiprazole - factors predicting favourable outcome. | Acta psychiatrica Scandinavica 20071201 |
| Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia. | International journal of clinical practice 20071201 |
| Ghrelin and leptin response to oral glucose challenge among antipsychotic drug-treated children. | Journal of clinical psychopharmacology 20071201 |
| Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders. | Journal of clinical psychopharmacology 20071201 |
| Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. | Journal of clinical psychopharmacology 20071201 |
| Repeated creatine kinase elevation under treatment with quetiapine, clozapine, and aripiprazole in an adolescent. | Journal of clinical psychopharmacology 20071201 |
| Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study. | The British journal of psychiatry. Supplement 20071201 |
| Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. | The Journal of clinical psychiatry 20071201 |
| Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis. | The Journal of clinical psychiatry 20071201 |
| Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management. | Clinical toxicology (Philadelphia, Pa.) 20071201 |
| Aripiprazole: effectiveness and safety under naturalistic conditions. | Experimental and clinical psychopharmacology 20071201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20071201 |
| Management of the behavioral and psychological symptoms of dementia. | Clinical interventions in aging 20071201 |
| Ziprasidone in the treatment of mania in bipolar disorder. | Neuropsychiatric disease and treatment 20071201 |
| Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review. | Neuropsychiatric disease and treatment 20071201 |
| Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies. | Neuropsychiatric disease and treatment 20071201 |
| A review of quetiapine in combination with antidepressant therapy in patients with depression. | Neuropsychiatric disease and treatment 20071201 |
| Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians. | Neuropsychiatric disease and treatment 20071201 |
| Current therapeutic options for Alzheimer's disease. | Current genomics 20071201 |
| Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action. | Neuroscience 20071130 |
| Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912. | European journal of pharmacology 20071128 |
| Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone. | Schizophrenia bulletin 20071101 |
| Possible psychotropic effects of Aripiprazole. | Schizophrenia research 20071101 |
| Effect of antipsychotics on creatine kinase activity in rat brain. | Basic & clinical pharmacology & toxicology 20071101 |
| Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study. | International clinical psychopharmacology 20071101 |
| Augmentation of aripiprazole with low-dose clozapine. | Pharmacotherapy 20071101 |
| Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20071101 |
| Psychotic episode associated with Bikram yoga. | The American journal of psychiatry 20071101 |
| Nonlinear mixed effects model analysis of the pharmacokinetics of aripiprazole in healthy Japanese males. | Biological & pharmaceutical bulletin 20071101 |
| Treatment of bipolar disorder: the evolving role of atypical antipsychotics. | The American journal of managed care 20071101 |
| Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials. | The Journal of clinical psychiatry 20071101 |
| Aripiprazole and perphenazine: no difference. | The Journal of clinical psychiatry 20071101 |
| A case of aripiprazole-related tardive akathisia and its treatment with ropinirole. | The Journal of clinical psychiatry 20071101 |
| Aripiprazole treatment of patients with borderline personality disorder. | The Journal of clinical psychiatry 20071101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20071101 |
| Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test. | European journal of pharmacology 20071031 |
| Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs. | Journal of medicinal chemistry 20071018 |
| Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20071001 |
| An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression. | International journal of geriatric psychiatry 20071001 |
| Metabolomic mapping of atypical antipsychotic effects in schizophrenia. | Molecular psychiatry 20071001 |
| A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study. | European psychiatry : the journal of the Association of European Psychiatrists 20071001 |
| Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics. | Progress in neuro-psychopharmacology & biological psychiatry 20071001 |
| Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action. | Pharmacology, biochemistry, and behavior 20071001 |
| Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain. | Naunyn-Schmiedeberg's archives of pharmacology 20071001 |
| Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder. | Progress in neuro-psychopharmacology & biological psychiatry 20071001 |
| Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. | Current medical research and opinion 20071001 |
| A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA). | Current medical research and opinion 20071001 |
| Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile. | Bioorganic & medicinal chemistry letters 20071001 |
| Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties. | Naunyn-Schmiedeberg's archives of pharmacology 20071001 |
| Adjunctive aripiprazole in combat-related posttraumatic stress disorder. | The Annals of pharmacotherapy 20071001 |
| Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients. | Journal of clinical psychopharmacology 20071001 |
| Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study. | Journal of clinical psychopharmacology 20071001 |
| Resolution of haloperidol-induced hyperprolactinemia with aripiprazole. | Journal of clinical psychopharmacology 20071001 |
| Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot. | Journal of clinical psychopharmacology 20071001 |
| Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies. | The American journal of psychiatry 20071001 |
| Aripiprazole: malignant syndrome. | Prescrire international 20071001 |
| Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial. | CNS spectrums 20071001 |
| Managing the acutely agitated and psychotic patient. | CNS spectrums 20071001 |
| Practical strategies for assessing and stabilizing bipolar patients in urgent situations. | The Journal of clinical psychiatry 20071001 |
| Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. | The Journal of clinical psychiatry 20071001 |
| Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo. | The Journal of clinical psychiatry 20071001 |
| A case of unexpected and selective remission of a 20-year history of ephedrine dependence following treatment with low-dose aripiprazole. | The Journal of clinical psychiatry 20071001 |
| Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphism. | Drug metabolism and pharmacokinetics 20071001 |
| Successful treatment of catatonia with aripiprazole in an adolescent with psychosis. | Journal of child and adolescent psychopharmacology 20071001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20071001 |
| Pharmacological causes of hyperprolactinemia. | Therapeutics and clinical risk management 20071001 |
| Review of olanzapine in the management of bipolar disorders. | Neuropsychiatric disease and treatment 20071001 |
| Usefulness of the dopamine system-stabilizer aripiprazole for reducing morphine-induced emesis. | European journal of pharmacology 20070910 |
| Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901 |
| Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. | Schizophrenia research 20070901 |
| Agitation associated with aripiprazole initiation. | Pharmacotherapy 20070901 |
| Aripiprazole: what is the role of dopamine D(2) receptor partial agonism? | The American journal of psychiatry 20070901 |
| Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. | The American journal of psychiatry 20070901 |
| Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. | The American journal of psychiatry 20070901 |
| Aripiprazole-induced tardive dyskinesia: the role of tamoxifen. | The American journal of psychiatry 20070901 |
| Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole. | The American journal of psychiatry 20070901 |
| An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. | CNS spectrums 20070901 |
| Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. | Bipolar disorders 20070901 |
| Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. | The Journal of clinical psychiatry 20070901 |
| Aripiprazole-induced psychosis: a case report of reexposure by stepwise up-titration. | The Journal of clinical psychiatry 20070901 |
| Tolerability and efficacy of aripiprazole in a case of psychotic anorexia nervosa comorbid with epilepsy and chronic renal failure. | Eating and weight disorders : EWD 20070901 |
| Olanzapine and acute urinary retention in two geriatric patients. | The American journal of geriatric pharmacotherapy 20070901 |
| In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling. | Journal of psychopharmacology (Oxford, England) 20070801 |
| Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence. | Journal of psychopharmacology (Oxford, England) 20070801 |
| Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. | Journal of affective disorders 20070801 |
| Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation. | Journal of neurochemistry 20070801 |
| Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications. | Human psychopharmacology 20070801 |
| Action of novel antipsychotics at human dopamine D3 receptors coupled to G protein and ERK1/2 activation. | Neuropharmacology 20070801 |
| Metabolic side effects of antipsychotic medication. | International journal of clinical practice 20070801 |
| GPCR functional selectivity has therapeutic impact. | Trends in pharmacological sciences 20070801 |
| Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study. | Journal of clinical psychopharmacology 20070801 |
| Acute pancreatitis and diabetic ketoacidosis in a schizophrenic patient taking olanzapine. | Journal of clinical psychopharmacology 20070801 |
| Haloperidol, olanzapine and risperidone reduce treatment failure compared to aripiprazole, quetiapine and ziprasidone in acute schizophrenia. | Evidence-based mental health 20070801 |
| Maintenance treatment in bipolar disorder: a focus on aripiprazole. | Expert review of neurotherapeutics 20070801 |
| Metabolic effects of the atypical antipsychotics. | Southern medical journal 20070801 |
| The role of lamotrigine in the management of bipolar disorder. | Neuropsychiatric disease and treatment 20070801 |
| Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070701 |
| Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats. | Psychopharmacology 20070701 |
| Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. | Neurochemical research 20070701 |
| Concomitant use of lamotrigine and aripiprazole increases risk of Stevens-Johnson syndrome? | International clinical psychopharmacology 20070701 |
| Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel. | Current medical research and opinion 20070701 |
| Aripiprazole--data on efficacy and associated mortality. | The British journal of psychiatry : the journal of mental science 20070701 |
| Aripiprazole--data on efficacy and associated mortality. | The British journal of psychiatry : the journal of mental science 20070701 |
| Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia. | Current opinion in investigational drugs (London, England : 2000) 20070701 |
| An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders. | The Journal of clinical psychiatry 20070701 |
| EEG Abnormalities in a patient taking Aripiprazole. | Psychiatry (Edgmont (Pa. : Township)) 20070701 |
| Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia? | Journal of psychopharmacology (Oxford, England) 20070601 |
| Aripiprazole in human milk. | The international journal of neuropsychopharmacology 20070601 |
| Abnormal glucose metabolism in patients treated with antipsychotics. | Diabetes & metabolism 20070601 |
| Aripiprazole acts as a selective dopamine D2 receptor partial agonist. | Expert opinion on investigational drugs 20070601 |
| Pharmacokinetics of aripiprazole and concomitant carbamazepine. | Journal of clinical psychopharmacology 20070601 |
| Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months. | Journal of clinical psychopharmacology 20070601 |
| Aripiprazole-induced obsessive-compulsive disorder: a report of 2 cases. | Journal of clinical psychopharmacology 20070601 |
| Aripiprazole for treatment of behavioural psychological symptoms of dementia. | The Australian and New Zealand journal of psychiatry 20070601 |
| New developments in the pharmacotherapy of cocaine abuse. | Addiction biology 20070601 |
| Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. | Journal of the American Academy of Child and Adolescent Psychiatry 20070601 |
| Relief from migraine headache with aripiprazole treatment. | Headache 20070601 |
| Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. | The Journal of clinical psychiatry 20070601 |
| The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. | The Journal of clinical psychiatry 20070601 |
| Schizophrenia symptoms remain stable during decreases from 2 antipsychotics to aripiprazole. | The Journal of clinical psychiatry 20070601 |
| Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder. | The Journal of clinical psychiatry 20070601 |
| Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches. | Dialogues in clinical neuroscience 20070601 |
| Quality of life in schizophrenic patients. | Dialogues in clinical neuroscience 20070601 |
| [Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients]. | Revista medica de Chile 20070601 |
| A case series: evaluation of the metabolic safety of aripiprazole. | Schizophrenia bulletin 20070501 |
| Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vitro samples. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501 |
| Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up. | Psychopharmacology 20070501 |
| A clinical study of the association of antipsychotics with hyperlipidemia. | Schizophrenia research 20070501 |
| Aripiprazole: pharmacology and evidence in bipolar disorder. | Expert opinion on pharmacotherapy 20070501 |
| Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials. | The Journal of clinical psychiatry 20070501 |
| Augmentation of clozapine treatment with aripiprazole. | The Journal of clinical psychiatry 20070501 |
| Aripiprazole and worsening of psychosis: a case report. | The Journal of clinical psychiatry 20070501 |
| Violent behavior. | Journal of psychiatric practice 20070501 |
| Intramuscular aripiprazole in the control of agitation. | Journal of psychiatric practice 20070501 |
| Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. | Journal of psychiatric practice 20070501 |
| Effects of comedication on the serum levels of aripiprazole: evidence from a routine therapeutic drug monitoring service. | Pharmacopsychiatry 20070501 |
| [Spectroscopic studies of aripiprazole]. | Guang pu xue yu guang pu fen xi = Guang pu 20070501 |
| Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070415 |
| Psychosis in a patient with Fabry's disease and treatment with aripiprazole. | Progress in neuro-psychopharmacology & biological psychiatry 20070413 |
| Aripiprazole in delusional parasitosis: Case report. | Progress in neuro-psychopharmacology & biological psychiatry 20070413 |
| Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats. | Psychopharmacology 20070401 |
| Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors. | Psychopharmacology 20070401 |
| The effect of atypical versus typical antipsychotics on tardive dyskinesia: a naturalistic study. | European archives of psychiatry and clinical neuroscience 20070401 |
| Unique pharmacological profile of aripiprazole as the phasic component buster. | Psychopharmacology 20070401 |
| The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice. | Psychopharmacology 20070401 |
| In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain. | Psychopharmacology 20070401 |
| Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole. | Journal of clinical pharmacy and therapeutics 20070401 |
| Use of atypical antipsychotics in the treatment of autistic disorder. | The Annals of pharmacotherapy 20070401 |
| Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. | Archives of general psychiatry 20070401 |
| An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder. | Journal of clinical psychopharmacology 20070401 |
| Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. | Journal of clinical psychopharmacology 20070401 |
| Aripiprazole and neuroleptic malignant syndrome. | Journal of clinical psychopharmacology 20070401 |
| Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression. | Journal of clinical psychopharmacology 20070401 |
| Worsening of obsessive-compulsive symptoms after treatment with aripiprazole. | Journal of clinical psychopharmacology 20070401 |
| Aripiprazole-induced hyponatremia: a case report. | The Journal of clinical psychiatry 20070401 |
| [Clinical observation on effect of Jieyu Anshen Decoction combined with aripiprazole in treating chronic schizophrenia]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070401 |
| Quetiapine in the treatment of schizophrenia and related disorders. | Neuropsychiatric disease and treatment 20070401 |
| An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health Administration. | Neuropsychiatric disease and treatment 20070401 |
| Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling. | Progress in neuro-psychopharmacology & biological psychiatry 20070330 |
| Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study. | Progress in neuro-psychopharmacology & biological psychiatry 20070330 |
| Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia. | Progress in neuro-psychopharmacology & biological psychiatry 20070330 |
| Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse. | Biological psychiatry 20070301 |
| Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition. | The Journal of pharmacology and experimental therapeutics 20070301 |
| Differential agonist and inverse agonist profile of antipsychotics at D2L receptors coupled to GIRK potassium channels. | Neuropharmacology 20070301 |
| Effectiveness and tolerability of aripiprazole in child and adolescent inpatients: a retrospective evaluation. | International clinical psychopharmacology 20070301 |
| Acute dystonia associated with aripiprazole in a child. | Journal of the American Academy of Child and Adolescent Psychiatry 20070301 |
| Management of agitation in the acute psychotic patient--efficacy without excessive sedation. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070301 |
| The stable patient with schizophrenia--from antipsychotic effectiveness to adherence. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070301 |
| The long term--maximising potential for rehabilitation in patients with schizophrenia. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070301 |
| Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: a retrospective chart review. | The Journal of clinical psychiatry 20070301 |
| Neuroleptic malignant syndrome induced by low dose aripiprazole in first episode psychosis. | Journal of psychiatric practice 20070301 |
| Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma. | Journal of psychiatric practice 20070301 |
| Aripiprazole worsening positive symptoms and memantine reducing negative symptoms in a patient with paranoid schizophrenia. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20070301 |
| Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient. | Pharmacopsychiatry 20070301 |
| Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia. | The Australian and New Zealand journal of psychiatry 20070301 |
| Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands. | Journal of medicinal chemistry 20070208 |
| Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole. | The international journal of neuropsychopharmacology 20070201 |
| [Psychotropic drug-induced change of weight: a review]. | Fortschritte der Neurologie-Psychiatrie 20070201 |
| Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole. | The international journal of neuropsychopharmacology 20070201 |
| Habituation deficits induced by metabotropic glutamate receptors 2/3 receptor blockade in mice: reversal by antipsychotic drugs. | The Journal of pharmacology and experimental therapeutics 20070201 |
| Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies. | Psychopharmacology 20070201 |
| Lamotrigine-induced Stevens-Johnson syndrome. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070201 |
| Continuing aripiprazole after stabilisation of a manic or mixed episode of bipolar I disorder delays relapse. | Evidence-based mental health 20070201 |
| Review: aripiprazole for schizophrenia--more high quality research required. | Evidence-based mental health 20070201 |
| Schizophrenia: multi-attribute utility theory approach to selection of atypical antipsychotics. | The Annals of pharmacotherapy 20070201 |
| Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine. | The Journal of clinical psychiatry 20070201 |
| Indexing of reports on aripiprazole augmentation of clozapine. | The Journal of clinical psychiatry 20070201 |
| Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic. | Neuropsychiatric disease and treatment 20070201 |
| Aripiprazole treatment of Asperger's syndrome in the acute psychiatric setting: case report. | Neuropsychiatric disease and treatment 20070201 |
| Pisa syndrome during aripiprazole treatment: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20070130 |
| Leukopenia and neutropenia induced by quetiapine. | Progress in neuro-psychopharmacology & biological psychiatry 20070130 |
| Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101 |
| Does antipsychotic polypharmacy increase the risk for metabolic syndrome? | Schizophrenia research 20070101 |
| The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment. | Psychopharmacology 20070101 |
| Aripiprazole augmentation for treatment of patients with inadequate antidepressants response. | Depression and anxiety 20070101 |
| Atypical antipsychotics in the treatment of mood disorders. | Current opinion in psychiatry 20070101 |
| Aripiprazole in the treatment of schizophrenia: a consensus report produced by schizophrenia experts in Italy. | Clinical drug investigation 20070101 |
| Adjunctive aripiprazole in bipolar I depression. | The Annals of pharmacotherapy 20070101 |
| Cmap ADHD and comorbid aggression algorithm. | Journal of the American Academy of Child and Adolescent Psychiatry 20070101 |
| A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. | The American journal of psychiatry 20070101 |
| Manic episode during treatment with aripiprazole. | The American journal of psychiatry 20070101 |
| Hyperglycemia in a 7-year-old child treated with aripiprazole. | The American journal of psychiatry 20070101 |
| Safety of aripiprazole: high serum levels in a CYP2D6 mutated patient. | The American journal of psychiatry 20070101 |
| Metabolic drug interactions with newer antipsychotics: a comparative review. | Basic & clinical pharmacology & toxicology 20070101 |
| Datapoints: The ups and downs of dosing second-generation antipsychotics. | Psychiatric services (Washington, D.C.) 20070101 |
| Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004. | Current medical research and opinion 20070101 |
| Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient. | Clinical neuropharmacology 20070101 |
| Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: a randomized trial. | The Journal of clinical psychiatry 20070101 |
| Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial. | The Journal of clinical psychiatry 20070101 |
| Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients. | Psychopharmacology bulletin 20070101 |
| Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. | The Journal of clinical psychiatry 20070101 |
| Aripiprazole-associated acute dystonia. | The Journal of neuropsychiatry and clinical neurosciences 20070101 |
| A case of aripiprazole-induced mania. | Pharmacopsychiatry 20070101 |
| Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder. | Pharmacopsychiatry 20070101 |
| Does aripiprazole have a role in treating cognitive impairment in Parkinson's disease? | The Journal of neuropsychiatry and clinical neurosciences 20070101 |
| 5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes. | Clinical and experimental pharmacology & physiology 20070101 |
| Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101 |
| Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101 |
| Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. | Clinical pharmacokinetics 20070101 |
| Mania in a case of hyperparathyroidism. | Psychosomatics 20070101 |
| A case of ciprofloxacin-induced acute polymorphic psychosis with a distinct deficit in executive functions. | Psychosomatics 20070101 |
| Cocaine use as a risk factor for ziprasidone-induced acute dystonia. | General hospital psychiatry 20070101 |
| Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial. | Psychopharmacology bulletin 20070101 |
| Newer antipsychotics and the rabbit syndrome. | Clinical practice and epidemiology in mental health : CP & EMH 20070101 |
| Normalization of prolactin with aripiprazole in a patient with psychotic depression and a comorbid pituitary microadenoma. | Psychosomatics 20070101 |
| Aripiprazole as the causative agent of neuroleptic malignant syndrome: a case report. | Primary care companion to the Journal of clinical psychiatry 20070101 |
| Possible new causes for false-positive diagnosis of pheochromocytoma: lamotrigine, aripiprazole, or the combination. | Primary care companion to the Journal of clinical psychiatry 20070101 |
| A case of acute dystonia after single dose of aripiprazole in a man with cocaine dependence. | The American journal on addictions 20070101 |
| Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders? | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101 |
| Efficacy and safety of aripiprazole in alcohol dependence. | The American journal of drug and alcohol abuse 20070101 |
| Epidemiology, diagnosis and management of mixed mania. | CNS drugs 20070101 |
| Aripiprazole in a patient susceptible to urinary side effects of antipsychotics. | The Israel journal of psychiatry and related sciences 20070101 |
| [Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics]. | L'Encephale 20070101 |
| [Clinical impact of aripiprazole in patients suffering from schizophrenia]. | L'Encephale 20070101 |
| Adjunctive treatment of acute mania: a clinical overview. | Acta psychiatrica Scandinavica. Supplementum 20070101 |
| Bipolar II disorder : epidemiology, diagnosis and management. | CNS drugs 20070101 |
| Atypical antipsychotics in children with pervasive developmental disorders. | Paediatric drugs 20070101 |
| Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. | BMC psychiatry 20070101 |
| The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101 |
| The prevalence and significance of substance use disorders in bipolar type I and II disorder. | Substance abuse treatment, prevention, and policy 20070101 |
| Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 diabetes mellitus: a case-report. | Annals of general psychiatry 20070101 |
| Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder. | Annals of general psychiatry 20070101 |
| [Dopamine agonists--clinical applications beyond Parkinson's disease]. | Neurologia i neurochirurgia polska 20070101 |
| Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches. | The American journal of drug and alcohol abuse 20070101 |
| The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance. | The American journal of drug and alcohol abuse 20070101 |
| Aripiprazole: in adolescents with schizophrenia. | Paediatric drugs 20070101 |
| Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole. | The Journal of neuropsychiatry and clinical neurosciences 20070101 |
| Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients. | Patient preference and adherence 20070101 |
| Clozapine: Current perspective. | Indian journal of psychiatry 20070101 |
| Mania as an unique life event. | Indian journal of psychiatry 20070101 |
| Paliperidone: the evidence of its therapeutic value in schizophrenia. | Core evidence 20070101 |
| Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist. | European journal of pharmacology 20061215 |
| Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: longevity of agonistic effects. | Brain research 20061208 |
| Aripiprazole is effective in the treatment of Tourette's disorder. | The international journal of neuropsychopharmacology 20061201 |
| A model of anticholinergic activity of atypical antipsychotic medications. | Schizophrenia research 20061201 |
| Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. | Schizophrenia research 20061201 |
| Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action. | Synapse (New York, N.Y.) 20061201 |
| Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study. | Human psychopharmacology 20061201 |
| Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20061201 |
| Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. | Psychopharmacology 20061201 |
| Acute treatment of mania: an update on new medications. | Current psychiatry reports 20061201 |
| Urinary obstruction with citalopram and aripiprazole combination in an elderly patient. | Journal of clinical psychopharmacology 20061201 |
| Clozapine augmented with aripiprazole in 5 patients with schizophrenia. | Journal of clinical psychopharmacology 20061201 |
| Efficacy with high-dose aripiprazole after olanzapine-related metabolic disturbances. | The Annals of pharmacotherapy 20061201 |
| Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients. | Therapeutic drug monitoring 20061201 |
| Treatment of psychosis: 30 years of progress. | Journal of clinical pharmacy and therapeutics 20061201 |
| Role of aripiprazole in treating mood disorders. | Expert review of neurotherapeutics 20061201 |
| Relapse rates in patients with schizophrenia receiving aripiprazole in comparison with other atypical antipsychotics. | The Journal of clinical psychiatry 20061201 |
| Long-term management strategies to achieve optimal function in patients with bipolar disorder. | The Journal of clinical psychiatry 20061201 |
| Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice. | Current medical research and opinion 20061201 |
| Treatments for late-life bipolar disorder. | The American journal of geriatric pharmacotherapy 20061201 |
| [The use of atypical antipsychotics in the long-term care of schizophrenia]. | L'Encephale 20061201 |
| A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder. | Neuropsychiatric disease and treatment 20061201 |
| Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia. | Neuropsychiatric disease and treatment 20061201 |
| Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series. | Journal of psychopharmacology (Oxford, England) 20061101 |
| Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study. | Current medical research and opinion 20061101 |
| Comparative effectiveness of second-generation antipsychotics and haloperidol in acute schizophrenia. | The British journal of psychiatry : the journal of mental science 20061101 |
| [The antipsychotic drug aripiprazole (ABILIFY)]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20061101 |
| Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine. | Experimental and clinical psychopharmacology 20061101 |
| Diagnostic and therapeutic challenges in narcolepsy-related psychosis. | The Journal of clinical psychiatry 20061101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20061101 |
| Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061020 |
| Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor. | British journal of pharmacology 20061001 |
| Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. | Psychopharmacology 20061001 |
| Aripiprazole in chronic schizophrenia: experiences in daily practice. | Acta psychiatrica Scandinavica 20061001 |
| Sex selection bias in schizophrenia antipsychotic trials. | Journal of clinical psychopharmacology 20061001 |
| Atypical neuroleptic malignant syndrome associated with aripiprazole. | Journal of clinical psychopharmacology 20061001 |
| Reversibility of antipsychotic treatment-related diabetes in patients with schizophrenia: a case series of switching to aripiprazole. | Diabetes care 20061001 |
| Hyperlipidemia following treatment with antipsychotic medications. | The American journal of psychiatry 20061001 |
| A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole. | Human psychopharmacology 20061001 |
| Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. | Journal of child and adolescent psychopharmacology 20061001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20061001 |
| Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties. | European journal of pharmacology 20060928 |
| A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. | Drug and alcohol dependence 20060915 |
| Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901 |
| Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901 |
| Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901 |
| Aripiprazole associated with severe exacerbation of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20060901 |
| Aripiprazole exposures reported to Texas poison control centers during 2002-2004. | Journal of toxicology and environmental health. Part A 20060901 |
| Meeting everyday challenges: antipsychotic therapy in the real world. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060901 |
| Differential metabolic effects of antipsychotic treatments. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060901 |
| The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia. | CNS spectrums 20060901 |
| In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles. | Naunyn-Schmiedeberg's archives of pharmacology 20060901 |
| Maintenance treatment of bipolar disorder: Applying research to clinical practice. | Journal of psychiatric practice 20060901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060901 |
| Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. | The Journal of clinical psychiatry 20060901 |
| Recurrent priapism associated with use of aripiprazole. | The Journal of clinical psychiatry 20060901 |
| Switching in the era of atypical antipsychotics. An updated review. | Postgraduate medicine 20060901 |
| Benefits of combining aripiprazole to clozapine: three case reports. | Progress in neuro-psychopharmacology & biological psychiatry 20060830 |
| The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine. | Psychopharmacology 20060801 |
| Neuroleptic malignant syndrome with aripiprazole and lithium: a case report. | Journal of clinical psychopharmacology 20060801 |
| A case of dose-dependent aripiprazole-induced conduction disturbance. | Journal of clinical psychopharmacology 20060801 |
| Long-term use of atypical antipsychotics in bipolar disorder. | Pharmacotherapy 20060801 |
| Aripiprazole for schizophrenia. Systematic review. | The British journal of psychiatry : the journal of mental science 20060801 |
| Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade. | CNS & neurological disorders drug targets 20060801 |
| Advanced pediatric psychopharmacology. | Journal of child and adolescent psychopharmacology 20060801 |
| A pilot study of aripiprazole in children and adolescents with Tourette's disorder. | Journal of child and adolescent psychopharmacology 20060801 |
| Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy? | Pharmacology, biochemistry, and behavior 20060801 |
| Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report. | The Journal of clinical psychiatry 20060801 |
| Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation. | The Journal of clinical psychiatry 20060801 |
| Haloperidol alone or in combination for acute mania. | The Cochrane database of systematic reviews 20060719 |
| Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex. | Brain research 20060712 |
| A case of Aripiprazole and extra pyramidal side effects. | Journal of psychopharmacology (Oxford, England) 20060701 |
| Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. | Journal of psychopharmacology (Oxford, England) 20060701 |
| Aripiprazole and the neuroleptic malignant syndrome. | Schizophrenia research 20060701 |
| Questionable advertising of psychotropic medications and disease mongering. | PLoS medicine 20060701 |
| Tolerability of high-dose aripiprazole in treatment-refractory schizophrenic patients. | The Journal of clinical psychiatry 20060701 |
| The metabolic effects of antipsychotic medications. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20060701 |
| Dementia with lewy bodies: therapeutic opportunities and pitfalls. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060701 |
| Use of aripiprazole for psychosis and agitation in dementia. | International psychogeriatrics 20060601 |
| Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study. | Progress in neuro-psychopharmacology & biological psychiatry 20060601 |
| Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. | Bipolar disorders 20060601 |
| Aripiprazole use in a pregnant schizoaffective woman. | Bipolar disorders 20060601 |
| Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. | Pharmacotherapy 20060601 |
| Neuroleptic malignant syndrome and aripiprazole. | Journal of the American Academy of Child and Adolescent Psychiatry 20060601 |
| Aripiprazole-induced acute dystonia. | The American journal of psychiatry 20060601 |
| Aripiprazole-related tardive dyskinesia. | CNS spectrums 20060601 |
| Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses. | The Journal of clinical psychiatry 20060601 |
| Aripiprazole-associated seizure. | The Journal of clinical psychiatry 20060601 |
| [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations]. | No to shinkei = Brain and nerve 20060601 |
| [Endocrine side effects among psychiatric patients treated with antipsychotics]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20060601 |
| Treatment of Alzheimer's disease across the spectrum of severity. | Clinical interventions in aging 20060601 |
| Risperidone in the treatment of bipolar mania. | Neuropsychiatric disease and treatment 20060601 |
| The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder. | Neuropsychiatric disease and treatment 20060601 |
| Bipolar disorders: treatment options and patient satisfaction. | Neuropsychiatric disease and treatment 20060601 |
| Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting. | Neuropsychiatric disease and treatment 20060601 |
| Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder. | Neuropsychiatric disease and treatment 20060601 |
| Elevated lipase and diabetic ketoacidosis associated with aripiprazole. | JOP : Journal of the pancreas 20060509 |
| A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA). | Schizophrenia research 20060501 |
| Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans. | International clinical psychopharmacology 20060501 |
| Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? | Movement disorders : official journal of the Movement Disorder Society 20060501 |
| Three cases of risperidone-induced enuresis. | Schizophrenia research 20060501 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Aripiprazole reduces acute mania compared with haloperidol in bipolar I disorder and causes fewer adverse effects. | Evidence-based mental health 20060501 |
| Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. | The American journal of psychiatry 20060501 |
| Psychiatric decision making in the adoption of a new antipsychotic in Germany. | Psychiatric services (Washington, D.C.) 20060501 |
| Aripiprazole pharmacotherapy of borderline personality disorder. | Pharmacopsychiatry 20060501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060501 |
| Aripiprazole for schizophrenia. | The Cochrane database of systematic reviews 20060419 |
| Manifestation of multiple sclerosis with paranoid-hallucinatory psychosis. | Journal of neurology 20060401 |
| Acute dystonia with low-dosage aripiprazole in Tourette's disorder. | The Annals of pharmacotherapy 20060401 |
| Naturalistic impact of second-generation antipsychotics on weight gain. | The Annals of pharmacotherapy 20060401 |
| Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. | The Journal of clinical psychiatry 20060401 |
| A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. | The Journal of clinical psychiatry 20060401 |
| High-dose aripiprazole in treatment-resistant schizophrenia. | The Journal of clinical psychiatry 20060401 |
| Clozapine augmentation with aripiprazole for negative symptoms. | The Journal of clinical psychiatry 20060401 |
| Aripiprazole in childhood and adolescence for Tourette syndrome. | Journal of child neurology 20060401 |
| Acute akathisia with suicidal ideation associated with low dose aripiprazole. | Psychiatry (Edgmont (Pa. : Township)) 20060401 |
| Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. | European journal of pharmacology 20060327 |
| Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase. | European journal of pharmacology 20060318 |
| Extrapyramidal side effects with atypical neuroleptics in bipolar disorder. | Progress in neuro-psychopharmacology & biological psychiatry 20060301 |
| Aripiprazole and suicidality. | International clinical psychopharmacology 20060301 |
| Aripiprazole-induced parkinsonism. | International clinical psychopharmacology 20060301 |
| Treatment-resistant bipolar disorder. | Molecular psychiatry 20060301 |
| Use of aripiprazole during late pregnancy in a woman with psychotic illness. | The Annals of pharmacotherapy 20060301 |
| [No rebound psychosis in a case of switching from clozapine to quetiapine]. | Psychiatrische Praxis 20060301 |
| Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060301 |
| Extensive weight loss in a patient with schizophrenia after switching from olanzapine to aripiprazole. A case report. | Pharmacopsychiatry 20060301 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060301 |
| Substance abuse in patients with schizophrenia. | Dialogues in clinical neuroscience 20060301 |
| A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. | Dialogues in clinical neuroscience 20060301 |
| [Clinical observations with aripiprazole in schizophrenia]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20060301 |
| Marked improvement in chronic tardive dyskinesia after changing to aripiprazole. | Psychiatry (Edgmont (Pa. : Township)) 20060301 |
| [Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug]. | Nederlands tijdschrift voor geneeskunde 20060218 |
| [Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug]. | Nederlands tijdschrift voor geneeskunde 20060218 |
| Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms. | Biochemical pharmacology 20060214 |
| Emerging treatments for bipolar disorder: safety and adverse effect profiles. | The Annals of pharmacotherapy 20060201 |
| Neuroleptic malignant syndrome and aripiprazole in an antipsychotic-naive patient. | Journal of clinical psychopharmacology 20060201 |
| Aripiprazole as a dopamine partial agonist: positive and negative effects. | Journal of clinical psychopharmacology 20060201 |
| An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. | Acta psychiatrica Scandinavica 20060201 |
| Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study. | Acta psychiatrica Scandinavica 20060201 |
| Aripiprazole-induced extrapyramidal side effects in a patient with schizoaffective disorder. | The Australian and New Zealand journal of psychiatry 20060201 |
| Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia. | Pharmacopsychiatry 20060201 |
| The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. | The Cochrane database of systematic reviews 20060125 |
| TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism. | Medical hypotheses 20060101 |
| Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies. | The pharmacogenomics journal 20060101 |
| Oxcarbazepine-induced thrombocytopenia. | Psychosomatics 20060101 |
| Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. | Psychosomatics 20060101 |
| Aripiprazole-induced movement disorder. | The American journal of psychiatry 20060101 |
| Interactions between antiepileptic and antipsychotic drugs. | Drug safety 20060101 |
| Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication. | The Journal of neuropsychiatry and clinical neurosciences 20060101 |
| Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health Centre. | BMC psychiatry 20060101 |
| Update on the biological treatment of aggression. | Actas espanolas de psiquiatria 20060101 |
| Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis. | Drug safety 20060101 |
| [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone]. | L'Encephale 20060101 |
| Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics. | American journal of Alzheimer's disease and other dementias 20060101 |
| Review of evidence that posttransplantation psychiatric treatment commonly affects prolactin levels and thereby influences graft fate. | General hospital psychiatry 20060101 |
| Aripiprazole in patients with Tourette syndrome. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20060101 |
| Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking. | Alcohol and alcoholism (Oxford, Oxfordshire) 20060101 |
| Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. | CNS drugs 20060101 |
| Pharmacological treatment of ambulatory schizophrenic patients in Belgium. | Clinical practice and epidemiology in mental health : CP & EMH 20060101 |
| Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20060101 |
| The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. | Molecular diagnosis & therapy 20060101 |
| [Pharmacology of antipsychotic drugs]]. | L'Encephale 20060101 |
| Economics of atypical antipsychotics in bipolar disorder: a review of the literature. | CNS drugs 20060101 |
| Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? | Drug safety 20060101 |
| Aripiprazole-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH). | American journal of therapeutics 20060101 |
| An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression. | Primary care companion to the Journal of clinical psychiatry 20060101 |
| Aripiprazole therapy for nicotine dependence. | Primary care companion to the Journal of clinical psychiatry 20060101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060101 |
| Adjunctive aripiprazole in treatment-resistant bipolar depression. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20060101 |
| Aripiprazole in the treatment of delirium. | Psychosomatics 20060101 |
| Tardive dystonia-associated prescription of aripiprazole. | The Journal of neuropsychiatry and clinical neurosciences 20060101 |
| Neuroacanthocytosis: presenting with depression. | The Journal of neuropsychiatry and clinical neurosciences 20060101 |
| Long-term management strategies to achieve optimal function in patients with bipolar disorder. | The Journal of clinical psychiatry 20060101 |
| Children with schizophrenia: clinical picture and pharmacological treatment. | CNS drugs 20060101 |
| A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole. | The Journal of the Oklahoma State Medical Association 20060101 |
| Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. | Psychopharmacology bulletin 20060101 |
| Adverse effects of atypical antipsychotics in the elderly: a review. | Drugs & aging 20060101 |
| Aripiprazole and delirium. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20060101 |
| Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation. | Clinical drug investigation 20060101 |
| Synthesis and bioactivity of aripiprazole derivatives. | Arzneimittel-Forschung 20060101 |
| Aripiprazole worsens psychosis: a case report. | Primary care companion to the Journal of clinical psychiatry 20060101 |
| Aripiprazole: the evidence of its therapeutic impact in schizophrenia. | Core evidence 20060101 |
| Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat. | Neuropharmacology 20051201 |
| Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. | The Journal of pharmacology and experimental therapeutics 20051201 |
| Priapism associated with oxcarbazepine, aripiprazole, and lithium. | Journal of the American Academy of Child and Adolescent Psychiatry 20051201 |
| Hypertension and aripiprazole. | The American journal of psychiatry 20051201 |
| Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis. | Archives of general psychiatry 20051201 |
| Overdoses and ingestions of second-generation antipsychotics in children and adolescents. | Journal of child and adolescent psychopharmacology 20051201 |
| The patient with schizophrenia taking aripiprazole: case report. | Psychiatria Danubina 20051201 |
| Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect. | Neuropsychiatric disease and treatment 20051201 |
| Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20051101 |
| Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. | The Annals of pharmacotherapy 20051101 |
| Treatment of withdrawal dyskinesia. | Journal of the American Academy of Child and Adolescent Psychiatry 20051101 |
| Weight change with atypical antipsychotics in the treatment of schizophrenia. | Journal of psychopharmacology (Oxford, England) 20051101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20051101 |
| Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist. | The journal of medical investigation : JMI 20051101 |
| Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies. | The Journal of clinical psychiatry 20051101 |
| Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex. | Neuroscience letters 20051028 |
| Synthesis of biologically active amines via rhodium-bisphosphite-catalyzed hydroaminomethylation. | Organic letters 20051027 |
| Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. | JAMA 20051019 |
| Second generation antipsychotics--aripiprazole revisited. | The Medical letter on drugs and therapeutics 20051010 |
| [Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug]. | Nederlands tijdschrift voor geneeskunde 20051008 |
| Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain. | The Journal of pharmacology and experimental therapeutics 20051001 |
| Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats. | Psychopharmacology 20051001 |
| Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study. | Journal of clinical psychopharmacology 20051001 |
| Catatonia and psychosis in a patient with AIDS: treatment with lorazepam and aripiprazole. | Journal of clinical psychopharmacology 20051001 |
| Diabetic ketoacidosis associated with aripiprazole. | Diabetic medicine : a journal of the British Diabetic Association 20051001 |
| Aripiprazole. | Expert opinion on pharmacotherapy 20051001 |
| Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder. | The Journal of clinical psychiatry 20051001 |
| Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. | The Journal of clinical psychiatry 20051001 |
| Is there a real difference between the first onset of efficacy for atypical antipsychotic monotherapies in acute bipolar mania? | The Journal of clinical psychiatry 20051001 |
| Treatment-emergent psychosis with aripiprazole. | The Journal of clinical psychiatry 20051001 |
| Aripiprazole: new drug. Just another neuroleptic. | Prescrire international 20051001 |
| Atypical antipsychotics: special formulations for acute agitation. | Journal of psychosocial nursing and mental health services 20051001 |
| Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20051001 |
| Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder. | Psychiatry research 20050915 |
| Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia. | The international journal of neuropsychopharmacology 20050901 |
| Case series on the use of aripiprazole for Tourette syndrome. | The international journal of neuropsychopharmacology 20050901 |
| Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats. | Psychopharmacology 20050901 |
| Clozapine-induced hyperlipidemia resolved after switch to aripiprazole therapy. | The Annals of pharmacotherapy 20050901 |
| Therapeutic monitoring of aripiprazole by HPLC with column-switching and spectrophotometric detection. | Clinical chemistry 20050901 |
| Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. | The British journal of psychiatry : the journal of mental science 20050901 |
| Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia. | The Australian and New Zealand journal of psychiatry 20050901 |
| Atypical antipsychotics and the burden of disease. | The American journal of managed care 20050901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050901 |
| [Determination of aripiprazole by nonaqueous reversed-phase high performance liquid chromatography]. | Se pu = Chinese journal of chromatography 20050901 |
| Atypical antipsychotics in the management of delirium: a review of the empirical literature. | Palliative & supportive care 20050901 |
| Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect. | Neuropsychiatric disease and treatment 20050901 |
| Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805 |
| Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats. | Neuropharmacology 20050801 |
| Aripiprazole in schizophrenia with cocaine dependence: a pilot study. | Journal of clinical psychopharmacology 20050801 |
| Safety and tolerability of emerging pharmacological treatments for bipolar disorder. | Bipolar disorders 20050801 |
| Reversal of symptomatic hyperprolactinemia by aripiprazole. | The American journal of psychiatry 20050801 |
| The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation. | Psychiatry (Edgmont (Pa. : Township)) 20050801 |
| ['Awakening': a confusing improvement during treatment with atypical antipsychotic agents]. | Nederlands tijdschrift voor geneeskunde 20050730 |
| The crossover approach to switching antipsychotics: what is the evidence? | Schizophrenia research 20050715 |
| High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050705 |
| Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics. | International clinical psychopharmacology 20050701 |
| The place of partial agonism in psychiatry: recent developments. | Journal of psychopharmacology (Oxford, England) 20050701 |
| Higher than Physician's Desk Reference (US) doses on atypical antipsychotics. | Expert opinion on drug safety 20050701 |
| One-year experience with aripiprazole exposures. | The American journal of emergency medicine 20050701 |
| Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients. | Journal of psychiatric practice 20050701 |
| Aripiprazole in children and adolescents: clinical experience. | Journal of child neurology 20050701 |
| Modern antipsychotic drugs: a critical overview. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20050621 |
| [Aripiprazole in the treatment of schizophrenia]. | Praxis 20050608 |
| Atypical antipsychotics for bipolar disorder. | The Psychiatric clinics of North America 20050601 |
| High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity. | Progress in neuro-psychopharmacology & biological psychiatry 20050601 |
| Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole. | The Journal of clinical psychiatry 20050601 |
| An African patient with ziprasidone intolerance. | The Journal of clinical psychiatry 20050601 |
| Fatal stroke with aripiprazole. | Prescrire international 20050601 |
| Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms? | European archives of psychiatry and clinical neuroscience 20050601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050601 |
| Aripiprazole: an overview of a novel antipsychotic. | Psychiatria Danubina 20050601 |
| Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders. | Neuropsychiatric disease and treatment 20050601 |
| Atypical presentations of atypical antipsychotics. | Psychiatry (Edgmont (Pa. : Township)) 20050601 |
| FDA warns antipsychotic drugs may be risky for elderly. | JAMA 20050525 |
| Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic. | European journal of pharmacology 20050516 |
| Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation. | Brain research 20050510 |
| Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors. | Journal of affective disorders 20050501 |
| [Haematological abnormalities during treatment with atypical antipsychotics]. | Psychiatrische Praxis 20050501 |
| [Rabbit syndrome due to olanzapine]. | Psychiatrische Praxis 20050501 |
| Partial dopamine agonists in schizophrenia. | Hospital medicine (London, England : 1998) 20050501 |
| Aripiprazole: pharmacology, efficacy, safety and tolerability. | Expert review of neurotherapeutics 20050501 |
| Overdose of aripiprazole, a new type of antipsychotic. | The Journal of emergency medicine 20050401 |
| Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer? | Current opinion in pediatrics 20050401 |
| Partial agonists in schizophrenia. | The British journal of psychiatry : the journal of mental science 20050401 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050401 |
| Aripiprazole in schizophrenia: consensus guidelines. | International journal of clinical practice 20050401 |
| Aripiprazole: novelty, adherence and understatement. | The international journal of neuropsychopharmacology 20050301 |
| Aripiprazole in a patient vulnerable to side effects. | The American journal of psychiatry 20050301 |
| Aripiprazole and depression in schizoaffective disorder. | The American journal of psychiatry 20050301 |
| Increased efficacy with addition of clozapine to aripiprazole: alternative explanations. | The Journal of clinical psychiatry 20050301 |
| The treatment of mixed states and the risk of switching to depression. | European psychiatry : the journal of the Association of European Psychiatrists 20050301 |
| Aripiprazole-induced seizure. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301 |
| Improvement in tardive dyskinesia with aripiprazole use. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301 |
| Galactorrhea with aripiprazole. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301 |
| Aripiprazole reduces alcohol use. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301 |
| Normalization of risperidone-induced hyperprolactinemia with the addition of aripiprazole. | Psychiatry (Edgmont (Pa. : Township)) 20050301 |
| Treatment of tics in tourette syndrome with aripiprazole. | Journal of clinical psychopharmacology 20050201 |
| Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine. | The American journal of psychiatry 20050201 |
| Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. | CNS spectrums 20050201 |
| Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness. | Expert opinion on pharmacotherapy 20050201 |
| Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLE. | Drug metabolism and pharmacokinetics 20050201 |
| Aripiprazole augmentation of clozapine: in refractory schizophrenia. | Psychiatry (Edgmont (Pa. : Township)) 20050201 |
| [Psychiatry]. | Revue medicale suisse 20050112 |
| Treatment of acute mania--from clinical trials to recommendations for clinical practice. | Human psychopharmacology 20050101 |
| Aripiprazole-associated dyskinesia. | The Annals of pharmacotherapy 20050101 |
| Pharmacokinetics of aripiprazole and concomitant lithium and valproate. | Journal of clinical pharmacology 20050101 |
| Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. | International clinical psychopharmacology 20050101 |
| Partial agonism and schizophrenia. | The British journal of psychiatry : the journal of mental science 20050101 |
| Managing bipolar disorder in the elderly: defining the role of the newer agents. | Drugs & aging 20050101 |
| The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. | The Journal of clinical psychiatry 20050101 |
| Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients. | The Journal of clinical psychiatry 20050101 |
| Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole. | Drugs of today (Barcelona, Spain : 1998) 20050101 |
| The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania. | The Journal of clinical psychiatry 20050101 |
| Aripiprazole and bone pain. | Psychosomatics 20050101 |
| Is leukopenia associated with divalproex and/or quetiapine? | Psychosomatics 20050101 |
| The art of prescribing. Principles of switching novel antipsychotic medications. | Perspectives in psychiatric care 20050101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050101 |
| Atypical antipsychotic therapy and hyperlipidemia: a review. | Essential psychopharmacology 20050101 |
| The dosing of atypical antipsychotics. | Psychosomatics 20050101 |
| Atypical experience: a case series of pediatric aripiprazole exposures. | Clinical toxicology (Philadelphia, Pa.) 20050101 |
| Aripiprazole (abilify) overdose in a child. | Clinical toxicology (Philadelphia, Pa.) 20050101 |
| [Combining effectiveness and tolerance]. | Krankenpflege Journal 20050101 |
| Tinnitus dopaminergic pathway. Ear noises treatment by dopamine modulation. | Medical hypotheses 20050101 |
| Atypical antipsychotics: newer options for mania and maintenance therapy. | Bipolar disorders 20050101 |
| The novel atypical antipsychotic aripiprazole as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. | Medical hypotheses 20050101 |
| Aripiprazole prescribing and continuation rates during psychiatric hospitalization. | The Annals of pharmacotherapy 20050101 |
| Spotlight on olanzapine in bipolar I disorder. | CNS drugs 20050101 |
| Aripiprazole for agitation in a 13-year-old girl with neuroleptic malignant syndrome. | International journal of adolescent medicine and health 20050101 |
| Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. | CNS drugs 20050101 |
| [Drug-induced diabetes mellitus: the exemple of atypical antipsychotics]. | Revue medicale de Liege 20050101 |
| A typical mood stabilizers: a 'typical role for atypical antipsychotics. | Acta psychiatrica Scandinavica. Supplementum 20050101 |
| Aripiprazole treatment for psychosis associated with Friedreich's ataxia. | General hospital psychiatry 20050101 |
| Aripiprazole in psychosis associated with Parkinson's disease. | The Journal of neuropsychiatry and clinical neurosciences 20050101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050101 |
| Management options for bipolar disorder in children and adolescents. | Paediatric drugs 20050101 |
| Antipsychotic poisoning in young children: a systematic review. | Drug safety 20050101 |
| Galactorrhea with aripiprazole. | Psychotherapy and psychosomatics 20050101 |
| Use of atypical antipsychotics in refractory depression and anxiety. | The Journal of clinical psychiatry 20050101 |
| Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication. | The Journal of neuropsychiatry and clinical neurosciences 20050101 |
| Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA. | PharmacoEconomics 20050101 |
| Atypicality of atypical antipsychotics. | Primary care companion to the Journal of clinical psychiatry 20050101 |
| Aripiprazole for the treatment of Tourette's disorder. | Primary care companion to the Journal of clinical psychiatry 20050101 |
| Aripiprazole in the treatment of delirium. | International journal of psychiatry in medicine 20050101 |
| Psychotropic drug utilization pattern among patients with schizophrenia. | Indian journal of psychiatry 20050101 |
| Aripiprazole augmentation of combination escitalopram and sertraline in the treatment of refractory obsessive-compulsive disorder. | Psychiatry (Edgmont (Pa. : Township)) 20050101 |
| Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain. | Molecular pharmacology 20041201 |
| Pharmacology of antipsychotics in the elderly: a focus on atypicals. | Journal of the American Geriatrics Society 20041201 |
| Optimizing atypical antipsychotic treatment strategies in the elderly. | Journal of the American Geriatrics Society 20041201 |
| A taxpayer-funded clinical trials registry and results database. | PLoS medicine 20041201 |
| Aripiprazole and atypical neuroleptic malignant syndrome. | Journal of the American Academy of Child and Adolescent Psychiatry 20041201 |
| Severe extrapyramidal symptoms in a 3-year-old boy after accidental ingestion of the new antipsychotic drug aripiprazole. | Pediatrics 20041201 |
| Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. | Progress in neuro-psychopharmacology & biological psychiatry 20041201 |
| Aripiprazole as an adjunctive treatment for refractory major depression. | Progress in neuro-psychopharmacology & biological psychiatry 20041201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041201 |
| Metabolic risk during antipsychotic treatment. | Clinical therapeutics 20041201 |
| [A new atypical antipsychotic with partial dopamine agonist effect (aripiprazole)]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201 |
| Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041115 |
| Aripiprazole and neuroleptic malignant syndrome. | International clinical psychopharmacology 20041101 |
| Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies. | CNS spectrums 20041101 |
| Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041101 |
| Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases. | The Journal of clinical psychiatry 20041101 |
| [Aripiprazol. An atypical neuroleptic with exceptional mechanisms of action] ]. | Medizinische Monatsschrift fur Pharmazeuten 20041101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041101 |
| Treatment of bipolar mania with atypical antipsychotics. | Expert review of neurotherapeutics 20041101 |
| Maintenance therapy for bipolar disorder: current and future management options. | Expert review of neurotherapeutics 20041101 |
| Chronic interictal psychosis responsive to aripiprazole. | Journal of clinical psychopharmacology 20041001 |
| Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. | Journal of clinical psychopharmacology 20041001 |
| The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research. | Bipolar disorders 20041001 |
| Aripiprazole for acute bipolar mania. | The American journal of psychiatry 20041001 |
| Atypical antipsychotics: matching receptor profile to individual patient's clinical profile. | CNS spectrums 20041001 |
| The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning. | Postgraduate medicine 20041001 |
| [Anticonvulsants and antipsychotics in the treatment of bipolar disorder]. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20041001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041001 |
| The effects of antipsychotic therapy on serum lipids: a comprehensive review. | Schizophrenia research 20040901 |
| Aripiprazole and psychotherapy for delusional disorder, erotomanic type. | Journal of the American Academy of Child and Adolescent Psychiatry 20040901 |
| Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. | Journal of psychopharmacology (Oxford, England) 20040901 |
| Dosage and administration issues of antipsychotic agents (and adjunctive medicines) in the acute stabilization of psychoses. | CNS spectrums 20040901 |
| [Aripiprazole: a new atypical antipsychotic drug]. | Fortschritte der Neurologie-Psychiatrie 20040901 |
| Possible increased efficacy of low-dose clozapine when combined with aripiprazole. | The Journal of clinical psychiatry 20040901 |
| Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report. | The Journal of clinical psychiatry 20040901 |
| [Expectation and development of atypical antipsychotic drugs]. | Therapeutische Umschau. Revue therapeutique 20040901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040901 |
| [Aripiprazole and Tourette syndrome]. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20040901 |
| [Expectations and developments in atypical antipsychotics]. | Praxis 20040825 |
| [Psychotropics and weight gain]. | Praxis 20040825 |
| The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome. | Sleep 20040801 |
| Worsening schizoaffective disorder with aripiprazole. | The American journal of psychiatry 20040701 |
| Aripiprazole-induced rabbit syndrome. | The Australian and New Zealand journal of psychiatry 20040701 |
| Pharmacological treatment strategies for schizophrenia. | Expert review of neurotherapeutics 20040701 |
| Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. | European journal of pharmacology 20040616 |
| Evidence-based pharmacotherapy of schizophrenia. | The international journal of neuropsychopharmacology 20040601 |
| Aripiprazole is effective for relapse prevention in people with chronic stable schizophrenia. | Evidence-based mental health 20040501 |
| Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability. | Clinical therapeutics 20040501 |
| The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release. | Brain research 20040402 |
| Aripiprazole (OPC-14597) fully substitutes for the 5-HT1A receptor agonist LY293284 in the drug discrimination assay in rats. | Psychopharmacology 20040401 |
| Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics. | Current drug targets 20040401 |
| Excessive somnolence from aripiprazole in a child. | Pharmacotherapy 20040401 |
| The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. | The Journal of clinical psychiatry 20040401 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040401 |
| Dose response and dose equivalence of antipsychotics. | Journal of clinical psychopharmacology 20040401 |
| Therapeutic monitoring of new antipsychotic drugs. | Therapeutic drug monitoring 20040401 |
| International Congress of Biological Psychiatry. 8-13 February 2004, Sydney, Australia. | IDrugs : the investigational drugs journal 20040301 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040301 |
| Selection of atypical antipsychotics for the management of schizophrenia. | The Annals of pharmacotherapy 20040201 |
| Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers. | Journal of clinical pharmacology 20040201 |
| Aripiprazole and Parkinson's disease psychosis. | The American journal of psychiatry 20040201 |
| Aripiprazole is effective against the symptoms of schizophrenia and schizoaffective disorder. | Evidence-based mental health 20040201 |
| Schizophrenia: from dopamine to glutamate and back. | Current medicinal chemistry 20040201 |
| Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions. | Current medicinal chemistry 20040201 |
| Pharmacogenomic-guided rational therapeutic drug monitoring: conceptual framework and application platforms for atypical antipsychotics. | Current medicinal chemistry 20040201 |
| A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. | Current medicinal chemistry 20040201 |
| Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia. | Current medicinal chemistry 20040201 |
| Aripiprazole, a novel atypical antipsychotic drug. | Pharmacotherapy 20040201 |
| Aripirazole-olanzapine combination for treatment of schizophrenia. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040201 |
| In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function. | European journal of pharmacology 20040101 |
| Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management. | Paediatric drugs 20040101 |
| Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism? | The Journal of clinical psychiatry 20040101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040101 |
| Using antipsychotic agents in older patients. | The Journal of clinical psychiatry 20040101 |
| Focus on aripiprazole. | Current medical research and opinion 20040101 |
| Dopamine partial agonists: a new class of antipsychotic. | CNS drugs 20040101 |
| Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. | Drugs 20040101 |
| Aripiprazole: in acute mania associated with bipolar I disorder. | CNS drugs 20040101 |
| Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience. | Clinical neuropharmacology 20040101 |
| Aripiprazole possibly worsens psychosis. | International clinical psychopharmacology 20040101 |
| Aripiprazole for schizophrenia. | The Cochrane database of systematic reviews 20040101 |
| Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns. | BMC psychiatry 20040101 |
| The case for atypical antipsychotics in bipolar disorder. | Perspectives in psychiatric care 20040101 |
| Clinical utilization of atypical antipsychotics in pregnancy and lactation. | The Annals of pharmacotherapy 20040101 |
| Dose response and atypical antipsychotics in schizophrenia. | CNS drugs 20040101 |
| The use of novel antipsychotics in the older patient with neurodegenerative disorders in the long-term care setting. | Journal of the American Medical Directors Association 20040101 |
| Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. | Drugs 20040101 |
| Efficacy of atypical antipsychotics in elderly patients with dementia. | The Journal of clinical psychiatry 20040101 |
| Drug development for anxiety disorders: new roles for atypical antipsychotics. | Psychopharmacology bulletin 20040101 |
| Drug therapy in schizophrenia. | Current pharmaceutical design 20040101 |
| Side effects of atypical antipsychotic drugs. | Current pharmaceutical design 20040101 |
| Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? | Current pharmaceutical design 20040101 |
| Atypical antipsychotic induced weight gain: pathophysiology and management. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101 |
| Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. | Drugs 20040101 |
| Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment. | Medical hypotheses 20040101 |
| Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101 |
| Impact of atypical antipsychotics on quality of life in patients with schizophrenia. | CNS drugs 20040101 |
| Olanzapine: a review of its use in the management of bipolar I disorder. | Drugs 20040101 |
| Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology. | CNS drug reviews 20040101 |
| A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. | The Journal of clinical psychiatry 20040101 |
| Second-generation antipsychotic medications in children and adolescents. | Journal of child and adolescent psychopharmacology 20040101 |
| Aripiprazole for maladaptive behavior in pervasive developmental disorders. | Journal of child and adolescent psychopharmacology 20040101 |
| Aripiprazole in the treatment of bipolar disorder in children and adolescents. | Journal of child and adolescent psychopharmacology 20040101 |
| The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. | Journal of child and adolescent psychopharmacology 20040101 |
| Aripiprazole augmentation in treatment-resistant depression. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101 |
| Sexuality and schizophrenia: a review. | Schizophrenia bulletin 20040101 |
| The metabolic syndrome during atypical antipsychotic drug treatment: mechanisms and management. | Metabolic syndrome and related disorders 20040101 |
| Open labeled, randomized, switch-over study of two fixed doses (10/15mg) of aripiprazole : to evaluate its safety and efficacy in the treatment of Indian patients of schizophrenia. | Indian journal of psychiatry 20040101 |
| Efficacy and tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders. | Indian journal of psychiatry 20040101 |
| Efficacy and tolerability of aripiprazole in patients with schizophrenia & schizoaffective disorders. | Indian journal of psychiatry 20040101 |
| Aripiprazole induced severe parkinsonian symptoms - a case report. | Indian journal of psychiatry 20040101 |
| Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. | The international journal of neuropsychopharmacology 20031201 |
| Relationship of atypical antipsychotics with development of diabetes mellitus. | The Annals of pharmacotherapy 20031201 |
| Aripiprazole. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031201 |
| Medication developments in the treatment of mental illness. | Behavioral healthcare tomorrow 20031201 |
| Aripiprazole-induced improvement in tardive dyskinesia. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20031201 |
| Aripiprazole in an adult with Asperger disorder. | The Annals of pharmacotherapy 20031101 |
| Aripiprazole and extrapyramidal symptoms. | Journal of the American Academy of Child and Adolescent Psychiatry 20031101 |
| European College of Neuropsychopharmacology - 16th Congress. 20-24 September 2003, Prague, Czech Republic. | IDrugs : the investigational drugs journal 20031101 |
| Mechanism of new antipsychotic medications: occupancy is not just antagonism. | Archives of general psychiatry 20031001 |
| Serotonin receptors: their key role in drugs to treat schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20031001 |
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. | The American journal of psychiatry 20030901 |
| Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. | The Journal of clinical psychiatry 20030901 |
| Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030801 |
| Treatment for mood and anxiety disorders: quetiapine and aripiprazole. | Current psychiatry reports 20030801 |
| [The next generation of 'atypical' antipsychotics: the role of positron emission tomography]. | Fortschritte der Neurologie-Psychiatrie 20030801 |
| Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein. | European journal of pharmacology 20030704 |
| Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. | European journal of pharmacology 20030704 |
| Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). | Journal of medicinal chemistry 20030703 |
| Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. | Archives of general psychiatry 20030701 |
| Antipsychotic medication and seizures: a review. | Drugs of today (Barcelona, Spain : 1998) 20030701 |
| Relating clinical trials to psychiatric practice: part I: the case of a 13-year old on aripiprazole and fluoxetine. | Journal of psychiatric practice 20030701 |
| Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. | Schizophrenia research 20030601 |
| Aripiprazole. | Nature reviews. Drug discovery 20030601 |
| Chlorpromazine equivalent doses for the newer atypical antipsychotics. | The Journal of clinical psychiatry 20030601 |
| Aripiprazole. | The Harvard mental health letter 20030601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20030601 |
| Advances in pharmacotherapy of psychotic disorders in the elderly. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20030601 |
| Aripiprazole: a new atypical antipsychotic drug. | The Annals of pharmacotherapy 20030501 |
| Aripiprazole: does partial dopaminergic agonism translate into clinical benefits? | The Annals of pharmacotherapy 20030501 |
| Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study. | Psychopharmacology 20030401 |
| Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic. | Expert opinion on investigational drugs 20030401 |
| Aripiprazole: quite possibly a new type of antipsychotic. | South Dakota journal of medicine 20030401 |
| H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030301 |
| alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. | European journal of pharmacology 20030221 |
| Aripiprazole (Abilify) for schizophrenia. | The Medical letter on drugs and therapeutics 20030217 |
| Aripiprazole. The newest antipsychotic agent for treatment of schizophrenia. | Journal of psychosocial nursing and mental health services 20030201 |
| Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic. | Drugs of today (Barcelona, Spain : 1998) 20030201 |
| Synthetic study on the unique dimeric arylpiperazine: access to the minor contaminant of aripiprazole. | Bioorganic & medicinal chemistry letters 20030106 |
| Aripiprazole: a review of its pharmacology and clinical use. | International journal of clinical practice 20030101 |
| New product intros. | Drug news & perspectives 20030101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20030101 |
| New developments in the pharmacotherapy of schizophrenia. | Journal of neural transmission. Supplementum 20030101 |
| Choice of maintenance medication for schizophrenia. | The Journal of clinical psychiatry 20030101 |
| Similarities and differences among antipsychotics. | The Journal of clinical psychiatry 20030101 |
| The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. | The Journal of clinical psychiatry 20030101 |
| Aripiprazole: profile on efficacy and safety. | Expert opinion on pharmacotherapy 20021201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021201 |
| Optimizing dosing in atypical neuroleptic monotherapy. | Dialogues in clinical neuroscience 20021201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021101 |
| Antipsychotics: impact on prolactin levels. | Expert opinion on pharmacotherapy 20021001 |
| Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. | The Journal of clinical psychiatry 20020901 |
| Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020801 |
| Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. | The Journal of pharmacology and experimental therapeutics 20020701 |
| Psychotropic drugs and the ECG: focus on the QTc interval. | Expert opinion on pharmacotherapy 20020501 |
| The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. | European journal of pharmacology 20020426 |
| Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis. | Current drug targets. CNS and neurological disorders 20020401 |
| Partial dopamine agonists in the treatment of psychosis. | Journal of neural transmission (Vienna, Austria : 1996) 20020301 |
| Aripiprazole. Abilitat, OPC 14597. | Drugs in R&D 20020101 |
| Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents. | CNS drugs 20020101 |
| Aripiprazole (Otsuka Pharmaceutical Co). | Current opinion in investigational drugs (London, England : 2000) 20020101 |
| Aripiprazole. | CNS drugs 20020101 |
| Biological perspectives. Aripiprazole: a third generation of antipsychotics begins? | Perspectives in psychiatric care 20020101 |
| Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | The Journal of clinical psychiatry 20011201 |
| Treatments for chronic psychosis. | Dialogues in clinical neuroscience 20011201 |
| Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, 'Goldilocks' actions at dopamine receptors. | The Journal of clinical psychiatry 20011101 |
| In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol. | Toxicology and applied pharmacology 20010601 |
| Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology. | Molecular pharmacology 20000101 |
| Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19990601 |
| Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland. | The Journal of pharmacology and experimental therapeutics 19960401 |